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INTRODUCTION
The :oi estonach of ruminants is inhabited by microoganisms that ferment dietary
carbohydrates and proteins, producing volatile fatty acids and microbial protein, which
in turn serve as the nutrients for the host metabolism. Fermentative digestion in the
rumen is oeneficial for substances that cannot be digested by the animal's own
hydrolytic enzymes. However, microbial fermentation of dietary protein, starch and
sugars and products of fermentation such as sugars and amino acids is accompanied by
losses in both energy and nitrogen. Therefore, a proper balance between microbial
fermentation and hydrolytic digestion is required for optimal production and
performance.
In order to maximize the efficiency of feed utilization in ruminants, research has
focused towards chemicals which promote adjustments in ruminal fermentation to
minimize losses in energy and nitrogen. Such manipulation should not affect the
beneficial aspect of microbial digestion such as fiber degradation and microbial
protein synthesis from nonprotein nitrogen. Monensin and lasalocid are two
antimicrobial compounds that have been widely used to alter rumen fermentation
characteristics to improve cattle performance. The success story of monensin and
lasalocid has stimulated testing of several antimicrobial compounds.
The objectives of this investigation were:
(1) To determine the sensitivity and resistance of rumen bacterial species to the
antimicrobial feed additives.
(2) To evaluate the feed additive potential of the antimicrobial compounds based on
in vitro lactic acid inhibition and alterations in volatile fatty acid production.
The following antimicrobial compounds were included in the study: avoparcin,
narasin, salinomycin, thiopeptin, tylosin, virginiamycin, R021 -6924/004 and
RO22-6W7/009.
SENSITIVITY AND RESISTANCE OF
RUMEN BACTERIA TO ANTIMICROBIAL
FEED ADDITIVES
ABSTRACT
Sensitivity and resistance of rumen bacterial species to avoparcin, narasin,
salinomycin, thiopeptin, tylosin, virginiamycin and two new ionphore antibiotics,
RO22-6924/004 and RO21-6447/009, were determined. Generally, antimicrobial
compounds were inhibitory to gram-positive bacteria and those bacteria that have
gram-positive-like cell wall structure. Minimum inhibitory concentration (MIC)
ranged from 0.09 to 24.0 ug/ml. Gram-negative bacteria were resistant at the
highest concentration tested (48.0 ug/ml). Based on the fermentation products
produced, rumen bacteria that produce lactic acid, butyric acid, formic acid or
hydrogen were sensitive and bacteria that produce succinic acid or ferment lactic
acid were resistant to the antimicrobial compounds. Selenomonas ruminantium was
the only major lactic acid-producing bacteria sensitive to all the antimicrobial
compounds tested. Avoparcin and tylosin appeared to be less inhibitory (MIC > 6.0
ug/ml) than the other compounds to the two major lactic acid-producing bacteria,
Streptococcus bo vis and Lactobacillus sp. lonophore compounds seemed to be more
inhibitory (MIC 0.09 - 1.50 ug/ml) than the non-ionophore compounds (MIC 0.75 -
12.0 ug/ml) to the major butyric acid-producing bacteria. Treponema bryantii
, an
anaerobic rumen spirochete was less sensitive to virginiamycin than to the other
antimicrobial compounds. It appears that minimum inhibitory concentration is not a
good indicator of the potency of the antimicrobial compounds in altering rumen
fermentation characteristics.
INTRODUCTION
Antimicrobial feed additives in animal feeds are used not only for the
control and treatment of infectious diseases but also for the enhancement of
growth and improvement of feed efficiency. Lasalocid and monensin are ionophore
antibiotics, that are used extensively in the cattle industry to improve the
efficiency of feed utilization (<t, 16). Ionophore antibiotics alter fermentation
characteristics resulting in favorable metabolic changes in the rumen (2, 3, 29).
Alterations in rumen fermentation are generally attributed to shift in microbial
population (6, 10). In vitro studies with pure cultures of rumen bacteria have
suggested that hydrogen-, formic-, acetic-, lactic-, and butyric acid-producing
bacteria tend to be sensitive, whereas succinic acid-producing and lactic
acid-fermenting bacteria tend to be resistant to lasalocid and monensin (6, 10,
17). The wide acceptance of lasalocid and monensin in the cattle industry has lead
to investigations of several antimicrobial compounds such as avoparcin (12),
laidlomycin (31), lysocellin (R.L. Preston, R.H. Pritchard and G.W. Wolfrom,
Lysocellin effects on the gain, feed intake and efficiency of growing-finishing
cattle. 3. Anim. Sci. 61:493, 1985), narasin (E.L. Potter, CO. Cooley and L.F.
Richardson. Effects of narasin upon the performance of feedlot cattle. 2. Anim.
Sci. 49:397-398, 1979), salinomycin (21), thiopeptin (15), and virginiamycin (9).
Narasin and salinomycin have been shown to be effective in improving feed
efficiency at a smaller dosage than either lasalocid or monensin (3). Rumen
metabolic changes induced by many of these antimicrobial compounds have been
shown to be similar to that of lasalocid and monensin (9, 13, 15, 21, 31). However,
the effects of these antimicrobial compounds on specific rumen bacterial species
have not been determined. The objective of the investigation was to determine the
sensitivity and resistance of rumen bacteria to avoparcin, narasin, salinomycin,
thiopeptin, tylosin, and virginiamycin. Two new ionophore antibiotics
RO22-6924/004 and RO21-6W/009 (antibiotic X-14547A produced by Streptomyces
antibioticus
, 37) were also included in the study.
MATERIALS AND METHODS
Organisms and culture media. The rumen bacterial strains used were
Anaerovibrio lipolytica 7553, Bacteroides amylophilus 70, B. ruminicola GA33, B.
succinogenes S85, Butyrivibrio fibrisolvens 49, Eubacterium cellulosolvens 5*95, E.
ruminantium GA 195, Lachnospira multiparus D32, Lactobacillus ruminis RF1, L.
vitulinus CL1, Megasphaera elsdenii B159, Ruminococcus albus 7, R. flavefaciens
C94, Selenomonas lactilytica PC18, S. ruminantium D, HD1, Streptococcus bo vis
7H4, Succinimonas amylolytica B24, Succinivibrio dextrinosolvens 0551, Treponema
bryantii and Veillonella alcalescens UW221.
All organisms were grown in prereduced anaerobically-sterilized media with
cysteine hydrochloride (0.05%) as the reducing agent. Culture media used were:
Brain-heart infusion broth (Baltimore Biologicals Laboratories, Baltimore, MD) for
S. bovis
;
MRS broth for Lactobacilli (8), lactate broth for A. lipolytica , M. elsdenii
and V. alcalescens (26) and H0% rumen fluid broth (10) for all other organisms. The
anaerobic techniques for preparing and dispensing media were that of Hungate et
al. (19) as modified by Holdeman et al. (18).
Antimicrobial compounds
. The following compounds were included in the
study: avoparcin (American Cyanamid Co., Wayne, N3), narasin (Elanco Products
Co., Indianapolis, IN), salinomycin (A.H. Robins Co., Richmond, VA), thiopeptin
(Fujisawa Pharmaceutical Co., Osaka, Japan), tylosin (Elanco Products Co.,
Indianapolis, IN), virginiamycin (Smith Kline Animal Health Products, Westchester,
PA) and ionophore antibiotics RO22-69/004 and RO21-6447/009 (Hoffmann-LaRoche
Co., Nutley, NJ). All antibiotics were dissolved in methanol except avoparcin,
which was dissolved in distilled water.
Determination of minimum inhibitory concentration
. Sensitivity or resistance
of rumen bacterial strains to antibiotics were determined by inoculating cultures
into media containing the following concentrations of antibiotics: 0, 0.09, 0.19,
0.38, 0.75, 1.5, 3.0, 6.0, 12.0, 24.0 and 48.0 ug/mL Three tubes were used for
each concentration and the control (0 ug/ml) tube received equivalent amount (10
ul) of methanol. Rubber-stoppered Hungate tubes (Bellco Glass Co., Vineland, N3)
containing 10 ml medium with or without antibiotics were inoculated with 0.1 ml of
an 18 h culture grown in the same medium without antibiotic. All incubations were
at 39°C for 96 hours. Growth was monitored at 24 h intervals by measuring
absorbance at 600 nm in a spectrophotometer (Bausch & Lomb). The minimum
inhibitory concentration (MIC) was the lowest antibiotic concentration in which
there was no measureable growth. MIC determination of each antibiotic and for
each strain was replicated three times.
Effects of antibiotics on growth of resistant bacteria. The rumen bacterial
strains that were resistant (MIC > 24.0 ug/ml) to the antibiotics were used. The
organisms were grown in 10-ml quantities of culture media containing or 6 ug
antibiotic/ml. Three tubes were used for each concentration and each tube was
inoculated with 0.1 ml of the inoculum. The inocula were from cultures grown for
18 to 24 h in the same medium without antibiotic. Growth was monitored by
measuring absorbance at 600 nm initially and at 1-hr intervals until maximum
absorbance was recorded. The experiment was replicated twice.
RESULTS
Sensitivity of lactic acid-producing rumen bacteria. Generally, the lactic
acid-producing rumen bacterial species were sensitive to the antimicrobial
compounds (Table 1). The MIC ranged from 0.09 to 12.00 ug/ml concentraton. S.
ruminantium was the only major lactic-acid producing bacteria resistant to all the
antimicrobial compounds. The highest concentration of the compounds tested was
*8.0 ug/ml. Avoparcin and tylosin appeared to be less inhibitory than other
antibiotics to S. bo vis and Lactobacillus spp.
Sensitivity of major butyric acid-producing rumen bacteria. Rumen bacterial
species that produce butyric acid as one of the major fermentation products were
sensitive to antibiotics (Table 2). The only exception was Megasphaera elsdenei
which was totally resistant to all the antibiotics. Based on MIC, ionophore
compounds seemed to be more inhibitory (MIC 0.09 - 1.50 ug/ml) than the
non-ionophore antimicrobial compounds (MIC 0.75 to 12.00 ug/ml).
Sensitivity of formic acid- and hydrogen-producing rumen bacteria. Rumen
bacterial species that produce formic acid as one of the major fermentation
products were sensitive to both ionphore and non-ionophore antimicrobial
compounds tested (Table 3). Among the hydrogen-producers only S. ruminantium
was resistant (Table it).
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Sensitivity of succinic acid-producing rumen bacteria . Bacterides sp.
Selenomonas sp. Succinimonas amylolytica and Succinivibrio dextrinosolvens were
resistant to all the antimicrobial compounds tested (Table 5). Treponema bryantii
,
a
saccharolytic rumen spirochete that produces acetate:formate:succinate at 1:1:0.5
molar proportion from glucose (32) was sensitive to all the antibiotics.
Sensitivity of lactic acid-fermenting rumen bacteria . Rumen bacterial
species that ferment lactic acid were generally resistant to all the antimicrobial
compounds (Table 6). However, Anaerovibrio lipolytica was sensitive to narasin and
salinomycin at 24 ug/ml concentration and Veillonella alcalescens was inhibited by
24 ug/ml concentration of tylosin and virginiamycin.
Effect of antimicrobial compounds on growth of resistant rumen bacteria.
The rate and extent of growth of S. ruminantium
, S. lactilytica , s. dextrinosolvens
and B. amylophilus were unaffected at 6 ug/ml concentration of antimicrobial
compounds (Table 7). A^ Lipolytica was not affected by avoparcin and thiopeptin.
However, ionophore antibiotics particularly narasin and salinomycin were effective
in reducing the growth of A. lipolytica . Tylosin and Virginiamycin also depressed
the growth of A. lipolytica
. The growth of B. ruminicola was affected by ionophore
antibiotics, thiopeptin, tylosin and virginiamycin. Avoparcin had no effect on B.
ruminicola
.
The growth of ML elsdenii was generally not affected by the presence
of antimicrobial compounds except for the slight reduction in the presence of
salinomycin, thiopeptin and tylosin. Virginiamcyin was the only antibiotic that
depressed the growth of ^ amylolytica. V. alcalescens was unaffected by
avoparcin, thiopeptin and tylosin, but virginiamycin depressed the growth by almost
50% of the control (Table 7).
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DISCUSSION
Antibacterial spectrum of antimicrobial compounds tested in this study were
remarkably similar despite wide differences in chemical structure and mode of
action. In general, antimicrobial compounds were inhibitory to gram-positive
bacteria such as Eubacterium
,
Lactobacillus and Streptococcus and to those
bacteria that often stain gram negative (Butyrivibrio , Lachnospira and
Ruminococcus) but have gram positive-type cell wall structure (7, 28).
Gram-negative bacteria such as bacteroides
, Megasphaera , Selenomonas
,
Succinimonas
,
Succinivibrio and VeiUonella were resistant to the antimicrobial
compounds. S. ruminantium B385, although stains gram negative was sensitive to all
the antimicrobial compounds. Strain B385 differs markedly from other strains of
Selenomonas
,
as it produces butyric acid and not succinic acid as the major
fermentation product (5). The cell wall structure of strain B385 has not been
determined and it is possible that it may have a gram positive cell wall structure.
T\ bryantii
,
an anaerobic rumen spirochete (32) was extremely sensitive to all the
antimicrobial compounds, but MIC of virginiamycin was higher (12 ug/ml) than that
of the other compounds. This is in contrast to the report that virginiamycin has
high antitreponemal activity (38). Virginiamycin is commercially available for the
prevention of swine dysentry, caused primarily by T. hyodysenteriae (27).
Although the effects of ionophore antibiotics used in this study on rumen
bacteria have not been previously determined, the antibacterial spectrum is in
general agreement with the activity of other ionophores, in that gram-positive
bacteria are sensitive and gram-negative bacteria are resistant (20, 36). The basic
mode of action of ionophore compounds is on transmembrane ion fluxes and the
17
dissipation of cation and proton gradients, thereby interfering primarily with
transport systems and ATP synthesis (3). Sensitivity and resistance pattern of
rumen bacteria to avoparcin and tylosin are in agreement with previous reports (1,
It, 33, 35).
Minimum inhibitory concentration of ionophore antibiotics towards various
rumen bacterial species were similar except RO21-6W/009, which tended to have
higher MIC than others. Among the nonionophore compounds, thiopeptin and
virginiamycin appeared to be more inhibitory to lactic acid-producing bacteria than
avoparcin and tylosin. The two major lactic acid-producing rumen bacteria, S. bovis
and Lactobacillus sp., involved in the onset of lactic acidosis syndrome in cattle
(30) were extremely sensitive to RO22-692V004, narasin, salinomycin, thiopeptin
and virginiamycin (MIC 0.09 to 3.0 ug/ml) but were less sensitive to avoparcin and
tylosin (MIC 3.0 to 12.0 ug/ml). Muir and Barreto (22) have reported that
thiopeptin was more inhibitory to S. bovis than virginiamycin, tylosin, and
ionophore antibiotics. Apparently, avoparcin and tylosin are not active against all
gram-positive bacteria. Wang et aL (35) reported that S^ bovis was sensitive to
tylosin only at high concentration (MIC > 100 ug/ml). Walton (3W noted that
avoparcin was not inhibitory to some gram-positive enteric streptococci and Dutta
and Devriese (11) have reported a number of lactobacilli against which avoparcin
had no activity. Thiopeptin and salinomycin have been shown to be effective in
preventing experimentally induced lactic acidosis in cattle (23-25). The effect of
other antimicrobial compounds on lactic acidosis have not been determined.
Sensitivity and resistance pattern of rumen bacteria, grouped on the basis
of major fermentation products produced, to the antimicrobial compounds used in
this study were similar to that of monensin and lasalocid (6, 10, 17). In general,
rumen bacteria that produce lactic acid, butyric acid, formic acid or hydrogen as
the major end product were sensitive and those bacteria that produce succinic acid
or ferment lactic acid were resistant. Ruminal changes associated with feeding
monensin or lasalocid are generally attributed to shift in bacterial population to
produce more propionic, less acetic, butyric, lactic acid and methane (2, 3, 29).
Increased propionate production is believed to be due to increased succinate-
producing and lactate-fermenting bacteria in the rumen of cattle fed antibiotics (2,
3). Although succinate producers and lactate fermenters were resistant to all the
antimicrobial compounds tested, the extent of propionate enhancement obtained
with the compounds both in vitro and in vivo was different (13, 21, M.B. Taylor
and T.G. Nagaraja, Report on XVII Conference on Rumen Function, 16.17 November
1983). Also, MIC of narasin, salinomycin, RO22-692'*/00<* to the lactic
acid-producing rumen bacteria were very similar to that of lasalocid and monensin.
However, salinomycin has been shown to be about 3-fold more potent than lasalocid
or monensin in inhibiting lactic acid production (25). Apparently, MIC is not a good
indicator of the potency of the antimicrobial compounds in altering rumen
fermentation characteristics.
18
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ABSTRACT
Batch culture fermentations were used to determine the effect of
avoparcin, lasalocid, monensin, narasin, salinomycin, thiopeptin, tylosin,
virginiamycin and two new ionophore compounds (RO22-6924/00<» and
R021-6<*<»7/009) on lactic acid and volatile fatty acid production. Preliminary
experiments were conducted with salinomycin to determine the effects of
incubation time and rumen fluid inoculum source on lactic acid and VFA
production. Maximum inhibition of lactic acid by salinomycin was at 6 h incubation,
but 12 h incubation showed a more graded response to antibiotic concentration.
Lactic acid inhibition by salinomycin was unaffected by rumen fluid inoculum
source. All antimicrobial compounds were effective in inhibiting lactic acid
production. Among the ionophores, narasin and salinomycin were more inhibitory
than others. Monensin and tylosin in combination was more effective than monensin
alone. Maximum alternations in VFA production by salinomycin were obtained in
fermentations incubated for 12 h with rumen fluid inoculum from low-grain fed
cattle. In general, total VFA concentration was unaffected by antimicrobial
compounds except that of RO22-6924/00<t, tylosin and virginiamycin which caused a
reduction at high concentrations. The acetate proportion was not affected by
avoparcin, RO22-692<t/00<*, RO21-6W/009, lasalocid, monensin, narasin and
salinomycin. However, tylosin, monensin and tylosin in combination, thiopeptin and
virginiamycin at high concentrations (> 6.0 ug/ml) increased the acetate
proportion. All compounds increased the molar proportion of propionate. Tylosin
and virginiamycin at high concentrations (> 6.0 ug/ml) decreased the proportion of
propionate. Monensin and tylosin combination had no effect on propionate portion.
Narasin and salinomycin were the most effective among the compounds tested, in
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enhancing propionate production. Ionophore antibiotics were more inhibitory to
butyrate production than the nonionophore compounds. Molar proportions of
isobutyrate, isovaierate and valerate were generally not affected by the addition
of antimicrobial compounds.
Introduction
Antimicrobial feed additives in animal diets are used not only for the
control and treatment of infectious diseases but also for the enhancement of
growth and improvement of feed efficiency. Lasalocid and monensin are ionophore
antibiotics that are used extensively in the cattle industry to improve the
efficiency of feed utilization (Brandt, 1982; Goodrich et al., 1985). Lasalocid and
monensin alter fermentation characteristics resulting in favorable metabolic
changes in the rumen (Bartley and Naragaja, 1982; Bergen and Bates, 1985;
Schelling, 1985). Among the favorable alterations in rumen fermentation, enhanced
propionate production at the expense of acetate and butyrate, inhibition of lactic
acid production, decreased methane and reduced proteolysis and deamination are
well documented (Bartley and Nagaraja, 1982; Bergen and Bates, 198t; Schelling,
198»). Because of the wide acceptance of lasalocid and monensin, several
antimicrobial compounds such as avoparcin Oohnson et al., 1979; Dyer et al., 1980)
laidlomycin (Spires and Algeo, 1983), lysocellin (wolfrom, 1983; Preston et al.,
1985), narasin (Dinusson et al., 1979; Potter et al., 1979), salinomycin (Merchen and
Berger, 1985), thiopeptin (Gill et al., 1979) and virginiamycin (DeMeyer and Van
Neval, 1985) are being investigated as possible feed additives. Rumen metabolic
changes induced by several of the potential feed additives have been shown to be
similar to that of lasalocid and monensin (Gill et al., 1979; Froetschel et al., 1983;
Spires and Algeo, 1983; Merchen and Berger, 1985). However, information on
relative efficacy of the antimicrobial compounds in altering rumen fermentation
characteristics is not available. The purpose of this investigation was to
quantitatively evaluate the ability of antimicrobial compounds to alter rumen
fermentation characteristics. The evaluation was based on in vitro inhibition of
lactic acid and alterations in VFA production.
Materials and Methods
Antimicrobial compounds. The following compounds were used in the in vitro
evaluation: avoparcin
,
lasalocid
,
monensin
,
narasin
,
tylosin
, salinomycin
,
thiopeptin and virginiamycin Also, two new ionophore antibiotics
,
R022-6924/004 and RO21-6487/009 (antibiotic X-1K547A produced by Streptomyces
antibioticus; Westley et aL, 1978) were also included in the evaluation. All
antibiotics were dissolved in methanol except avoparcin, which was dissolved in
distilled water.
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American Cyanamid Co., Wayne, NJ.
2
Hoffmann-LaRoche Inc., Nutley, N3.
Elanco Products Co., Indianapolis, IN.
A.H. Robins Co., Richmond, VA.
Fuji-Sawa Pharmaceutical Co., Osaka, Japan.
Smith Kline Animal Health Products, Westchester, PA).
Effect on lactic acid production
. Batch culture fermentations with glucose as the
substrate were set up to determine the effect of antimicrobial compounds on L(+)
and D(-) lactic acid production. Preliminary experiments were conducted to
determine the effects of incubation time (3, 6, 9 and 12 h) and rumen fluid
inoculum source (cattle fed alfalfa hay to grain diet at 80:20, 50:50 and 20:80
ratio) on L(+) and D(-) lactic acid production from glucose fermentation. Only
salinomycin was used in the preliminary experiments.
To determine the effect of incubation time, rumen fluid from a
rumen-fistulated steer fed a diet of alfalfa hay (IFN 1-00-063) (80%) and grain
(20%) was used. The composition of the grain portion of the diet was 49.2% rolled
corn (IFN 4-02-931), 49.2% cracked sorghum grain (IFN 4-08-139), 1.0% dicalcium
phosphate (IFN 6-01-080), .25% trace mineral salts (IFN 6-04-152) and .1% vitamins
A and D mixture. Rumen fluid was obtained 4 h postfeeding and strained through
four layers of cheese cloth. Fifteen ml strained rumen fluid and 5 ml mineral
buffer (pH 6.8, Dennis et al., 1981a) were incubated with 3.0 g glucose in 50 ml
polyethylene centrifuge tubes. Salinomycin, dissolved in methanol was added at 0,
.38, .75, 1.5, 3.0, 6.0, 12.0 ug/ml incubation mixture. Control tubes (0 ug/ml)
received an equivalent amount of methanol. Each tube was flushed with COo gas,
stoppered with rubber stoppers equipped with bunsen valves and incubated at 39 C.
Fermentations were set up in duplicate. Sample aliquots were removed at 3, 6, 9
and 12 h and pH recorded. Samples were deproteinized with 8% perchloric acid and
centrifuged at 48,400 x g for 20 min and the cell-free supernatant was analyzed
for L (+) and D (-) lactic acid concentrations (Dennis et al., 1981b). The experiment
was replicated three times.
To determine the effect of rumen fluid inoculum source on lactic acid
production, rumen fluid was obtained from three steers fed a diet of alfalfa hay
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and grain at 80:20, 50:50 and 20:80 ratio, respectively. The composition of grain
diet was as before. Batch culture fermentations were set up as before and samples
collected at the end of 12 h incubation were used to record pH and measure L (+)
and D (-) lactic acid concentrations. The experiment was replicated three times.
The effects of avoparcin, RO22-6924/004, RO21-6W/009, lasalocid,
monensin, narasin, salinomycin, tylosin, thiopeptin, virginiamycin and monensin and
tylosin combination (3:1) on L (+) and D (-) lactic acid production were determined.
Rumen fluid inoculum was from a steer fed alfalfa hay and grain (80:20) diet and
incubation time was 12 h. Antibiotics were added at 0, .09, .19, .38, .75, 1.5, 3.0,
6.0, 12.0 and 24.0 ug/ml. Fermentations were set up in duplicates and final pH, L
(+) and D (-) lactic acids were determined as before. Each antibiotic was tested at
least three times with rumen fluid collected on different days.
In order to quantitate the effects of antimicrobial compounds on L(+) and
D(-) lactic acids, 1C50 (Inhibitory concentration) defined as concentration (ug/ml)
required to inhibit L(+) and D(-) lactic acids by 50% of the control (0 ug/ml) was
calculated.
Effects on VFA production . Batch culture fermentations with a mixture of
carbohydrate, protein and B vitamins as substrate were set up to determine the
effects of antimicrobial compounds on VFA production. Preliminary experiments
were conducted to determine the effects of incubation time (6, 12, 18, and 24 h)
and rumen fluid inoculum source (cattle fed alfalfa hay and grain diet at 80:20,
50:50 and 20:80 ratio) on VFA production. Only salinomycin was used in the
preliminary experiments.
To determine the effect of incubation time, rumen fluid from a
rumen-fistulated steer fed a diet of alfalfa hay and grain (50:50) was used. The
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composition of the grain portion of the diet was as before. Rumen fluid from
collected 4 to 5 h postfeeding and strained through four layers of cheesecloth.
Fifteen ml strained rumen fluid and 15 ml mineral buffer (pH 6.8) were incubated
with a substrate mixture consisting of glucose, xylose, cellobiose, maltose, urea (50
mg each), casein hydrolyzate (100 mg) and B vitamins (300 ul; Scheifinger et al.,
1975) in 50 ml- polyethylene centrifuge tubes. Salinomycin, dissolved in methanol
was added at 0, .76, 1.5, 3.0, 6.0, 12.0, 24.0 and 48.0 ug/ml incubation mixture.
Control tubes (0 ug/ml) received an equivalent amount of methanol. Each tube was
flushed with C0
2 gas, stoppered with rubber stoppers equipped with bunsen valves
and incubated at 39 C. Fermentations were set up in duplicates for each
concentration. Sample aliquots were removed at 6, 12, 18 and 24 h and pH
recorded. Samples were then acidified with 6N HC1 and analyzed for VFA in a gas
chromatograph (Bartley et al., 1979). The experiment was replicated three times.
To determine the effect of rumen fluid inoculum source on VFA production,
rumen fluid was collected from three steers fed a diet of alfalfa hay and grain at
80:20, 50:50 and 20:80 ratio, respectively. The composition of the grain portion of
the diet was as before. Batch culture fermentations were set up as before and
samples were collected at the end of 12 h incubation to record pH and analyze for
VFA concentration. The experiment was replicated three times.
The effects of avoparcin, RO22-6924/004, RO21-6447/009, lasalocid,
monensin, narasin, salinomycin, tylosin, thiopeptin, virginiamycin and monensin
and tylosin combination (3:1) on VFA production were determined. Rumen fluid
inoculum was from a steer fed alfalfa hay and grain (50:50) diet and incubation
time was for 12 h. Antimicrobial compounds were added at 0, .75, 1.5, 3.0, 6.0,
12.0, 24.0 ug/ml. Fermentations were set up in duplicate and VFA concentration
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measured as before. Each antibiotic was tested at least three times with rumen
fluid collected on different days.
In order to quantitate the effects of antimicrobial compounds on VFA
production an EC25 (Enhancement concentration) defined as the concentration
(ug/ml) required to enhance propionate production by 25% of the control (0 ug/ml)
and 1C25 (Inhibitory concentration) defined as the concentration (ug/ml) required
to reduce acetate:propionate ratio or butyrate by 25% of the control (0 ug/ml)
were calculated.
Statistical analyses . Experiments dealing with incubation time and diet
effects (rumen fluid inoculum source) were analyzed by General Linear Models
procedure of Statistical Analysis Systems (SAS, 1982) using a randomized block
design, with replication as the blocking factor and a two-way treatment structure
utilizing all the incubation times or diets and antibiotic concentrations
combinations. The data on the effects of various antimicrobial compounds on lactic
acid and VFA productions were analyzed by GLM procedure of SAS, using a
randomized complete block design and a one-way treatment structure with
antibiotic concentration as the treatment variable and replication as the blocking
variable. Least square means were tested by least significant differences only
after F tests were significant.
Results
Effects of incubation time and salinomycin concentration on lactic acid
production
.
Total lactic acid concentration increased progressively (P<.05) with a
concurrent decrease in pH with increased incubation time in both control (no
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antibiotic) and salinomycin-treated fermentations (table 1). Both L(+) and D(-)
lactic acid concentrations were highest at 12 h incubation. The extent of L(+)
lactic acid increase over incubation time was much higher than that of D(-) lactic
acid. D(-) lactic acid accounted for 55* of the total in the control at 3 h but
declined to 6-10* with further incubation. Salinomycin-treated fermentations had
higher final pH and lower L(-) and D(-) lactic acid concentrations than the control
(table 1). However, the proportion of D(-) lactic acid was higher in the
salinomycin-treated fermentation than the control. Maximal inhibition of lactic
acid by salinomycin was at 6 h incubation (table 2). The 12 h incubation showed a
more graded response to the salinomycin concentration than did the other
incubation times. Accordingly, IC50 for L(+) and total lactic acid was lowest at 6
h incubation (table 2).
Effects of rumen fluid inoculum source and salinomycin concentration on
lactic acid production
. Total and L(+) lactic acid concentrations at the end of 12 h
incubation in the control were lowest in the fermentation with rumen fluid
inoculum from a high-grain (80%) fed steer and highest in the fermentation with
rumen fluid inoculum from cattle fed a low-grain diet (table 3). Difference in final
pH were reflective of lactic acid concentration. Apparently D(-) lactic acid
concentration was unaffected by the rumen fluid inoculum source. However, the
proportion of D(-) lactic acid was higher in the control fermentations with rumen
fluid from high-grain fed cattle than in the fermentations with rumen fluid from
low-grain fed cattle (21.9 vs 10.4*). Addition of salinomycin to the fermentation
resulted in higher pH and lower L(+), D(-) and total lactic acid concentrations than
the control with no antibiotic. Apparently, the extent of inhibition of L(+) and
total lactic acid was unaffected by the rumen fluid inoculum source (table 3).
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EFFECTS OF INCUBATION TIME AND SALINOMYCIN
CONCENTRATION ON LACTIC ACID CONCENTRATION FROM IN
VITRO FERMENTATION OF GLUCOSE"
Incubation
time and
antibiotic
concentration
Mg/ml
3 h
.38
.75
I.JO
3.00
£.00
12.00
pH Total LM D<->
mg/ml
6.22^
6.33 61
6.36b '
6.32bl
6.34 bl
6.38 b<
.06"
.OS
6,
.06 c
.03 c
Of
.06bc .02°
.09bc .03c
6. 33bc .09'
be
,03 c
.08 c
.03c
.0?
.0»c
.04c 66.0
.06c 66.0
.06c 66.0
DM
%
55.1
50.0
60.0
66.0
Percent inhibition
Total L<») D(T
56.0 86.0 6S.0
62.4 56.3 68.1
57.5 54.4 60.5
55.8 54.0 59.1
35.7
35.7
46.3
44.0
36.9
23.1
6 h
.38
.75
1.50
3.00
6.00
12.00
5.10d 2.09d 1.96d .13c 6.8
.06^ 14.5 71.5 73.0 53.3
.05c 28.9 90.1 92.4 63.5
.05 c 33.9 92.7 95.4 63.8
.07^ 38.3 91.2 94.7 51.8
.08c 50.0 91.0 95.3 39.1
.U c 58.9 90.3 92.3 14.9
9 h
.38
.75
1.50
3.00
6.00
12.00
4.54* 4. 18' 3.88e
5.04** 1.99be 1.69be
5.29 1* .73** .571*
5.30 1* .58bd AUb6
5.32**
.53bd .38bc
5.34 1* .62bd .31 bc
5.31° .50 bc .30'bc
.30° 7.» - - -
,30 d 18.2 53.2 58.1 0.0
.16c 22.2 82.0 84.S 46.0
.14c 23.1 (5.6 88.0 55.6
.15c 29.4 86.9 90.1 31.2
.3l d 50.0 84.3 91.8 -3.3
.20c 38 87.8 92.3 37.6
4.33e 5.65* 5.04f .61° 10.8
.38 4.80be 2.59bf 2.06bf .53* 20.6 53.1 57.7 15.2
.75 4.92" 1.57bl I.14 bf .43d 28.5 72.5 77.3 30.2
1.50 4.9!M 1.24 b<! .75bd .49d 38.8 78.0 84.8 20.9
3.00 5.0l bf 1.08be .64bd .44d 38.5 81.3 87.3 31.4
6.00 5.07bd .IS 1* .57be
.38bd 40.2 83.3 88.5 37.1
12.00 5.08 1*
.81 bd .43bc
.38bd 46.4 85.3 90.9 37.1
SI 10 .24 .21'
.07
Diilerent from ug/ml concentration within each incubation time (P<.05).
' ''Column means within each concentration bearing the same superscript do
not differ (P<.05).
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TABLE 2. EFFECT OF INCUBATION TIME ON LACTIC ACID INHIBITION BY
SALINOMYCIN
Incubaton IC50,a us/ml
time, h Total lactic L(+) Lactic D(-) Lactic
3 .34 .52 .28
6 .27
.26 .36
9 .36 .33 1.06
12 .36 .33 M2.00
aIC50 is the salinomycin concentration required to inhibit lactic acid by 50* of
the control.
TABLE 3. EFFECTS OF RUMEN FLUID INOCULUM SOURCE AND
SALINOMYCIN CONCENTRATION ON LACTIC ACID
CONCENTRATION FROM IN VITRO FERMENTATION
35
Rumen fli
inoculum :
and antibi
lid
source
otic
tion PH
Lactic acid Percent in
Total L(+)
hibition
Concentre
Mg/ml
Total L(+)
mg/ml
-
DW K-)
%
D(-)
20% grain diet
4.3l c 5.60c 5.02c .59c 10.4 — — —
.38 4.77bc 1.82bc 1.28bc .54c 30.8 67.5 74.7 8.5
.75 4.89bc 1.23bc .82bc .41° 34.5 78.3 84.0 26.4
1.50 4.90bc 1.10bc .74bc .36bc 33.8 80.3 85.4 34.2
3.00 4.94bc l.I2bc .73bc .40bc 35.8 79.8 85.5 27.2
6.00 5.00bc .95 bc .60bc .35bc 36.7 83.0 88.1 34.5
12.00 5.07bc .82bc .46bc .35 bc 46.3 85.2 90.8 32.8
50% grain diet
4.22d 4.63 d 3.85d .79c 1.68 — - —
.38 4.69bc 1.78bc 1.1 2bc .66° 38.6 62.3 71.5 15.5
.75
1.50
4.70bc
4.89bc
1.36bc
.99bc
.78bc
.53bcd
.58c
.46bc
44.3
46.4
71.0
78.9
80.1
86.4
24.5
41.7
3.00 4.87bc 1.00bc .52bcd .49bc 48.5 78.5 86.7 37.4
6.00 4.90bc .93bc .49bc .44bc 47.3 80.0 87.3 43.7
12.00 4.95bc .77bc .38bc .39bc 51.0 83.5 90.3 49.2
80% grain diet
.38
4.47cd
5.22bd
3.60e
1.1
3
bd
2.80e
79bcd
.78c
.34bd
21.9
31.2 68.8 72.6 54.9
.75
1.50
5.29bd
5.30bd
.75bd
.45
bd
.50 bc
,7bed
.25bd
.18bd
33.9
40.6
78.6
87.1
81.9
90.2
65.0
76.0
3.00 5.30bd .40bd ;25bd .15 bd 41.7 88.5 90.9 79.3
6.00 5.32bd .38bd .23bc .14bd 35.8 88.7 91.0 80.4
12.00 5.36bd .28bd .I7 bd .ll bd 39.3 91.8 93.8 84.5
SE .07 .16 .13 .05
i^Least square means and standard error (SE).
Different from Mg/ml concentration within each diet (P<.05).
c
'
'
eColumn means within each concentration bearing the same superscript do
not differ (PC05).
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However, the extent of D(-) lactic acid inhibition by salinomycin was higher in
fermentations with rumen fluid inoculum from cattle fed a high-grain diet than
that of the fermentations with rumen fluid inocula from cattle fed a medium- or
low-grain diet (table 5). Accordingly 1C50 of salinomycin for L(+) and total lactic
acid was unaffected by the rumen fluid inoculum source and 1C50 for D(-) lactic
acid was lowest in fermentations containing rumen fluid from high-grain fed cattle
(table *).
Effects of antimicrobial compounds on lactic acid production. Fermentation
of glucose with rumen fluid from cattle fed a low-grain diet resulted in low pH (<
4.5) and high lactic acid concentration at the end of 12 h incubation. L(+) lactic
acid was the predominant isomer and D(-) isomer usually accounted for 10-20% of
the total lactic acid. Fermentations treated with antimicrobial compounds had
higher final pH and lower I_(+), D(-) and total lactic acid concentration than the
control with no antibiotic (tables 5-15). In all instances, the extent of L(+) and
total lactic acid inhibition appeared to be dose dependent at low antibiotic
concentrations (.09 to 1.5 ug/ml). All antimicrobial compounds except thiopeptin
(table 12) increased D(-) lactic acid production at low concentrations but were
inhibitory at higher concentrations. Also, the extent of D(-) lactic inhibition was
lower than that of the inhibition of L(+) lactic acid. Consequently, the proportion
of D(-) lactic acid in antibiotic-treated fermentation were higher than that of the
control. Maximal inhibition of D(-) lactic acid was observed with thiopeptin and
virginiamycin-treated fermentations (tables 16 and 17).
Among ionophore antibiotics narasin and salinomycin were most effective
and RO21-6447/009 was least effective in inhibiting lactic acid production. Based
on IC50 for total lactic acid, lasalocid appeared to be more inhibitory than
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TABLE it. EFFECT OF RUMEN FLUID INOCULUM SOURCE ON LACTIC ACID
INHIBITION BY SALINOMYCIN
Rumen fluid
inoculum IC50,a MS/ml
source Total lactic L(+) Lactic D(-) Lactic
20* Grain diet .28
.25 > 12.00
50* Grain diet .31 .27 > 12.00
80* Grain diet .28
.25 .35
aIC50 is the salinomycin concentration required to inhibit lactic acid by 50* of
the control.
3e
TABLE 5. EFFECT OF AVOPARCIN ON LACTIC ACID CONCENTRATION FROM IN
VITRO FERMENTATION OF GLUCOSE3
Final
pH
Lactic acid Percent Inhibition
concentration Total U+)
mg/ml
K-) D(-)
%
Total L( + ) DM
4.29 4.54 3.66 .88 19.9 - - -
.09 4.31 4.18 3.35 .83 20.1 6.8 7.0 3.1
.19 4.36 4.06 3.08 .98 24.4 10.4 13.8 -26.8
.38 4.42 3.66c 2.6 l b 1.05 29.2 19.5 27.0 -40.0
.75 4.5 5C 3.09d 2.09c 1.00 32.7 30.0 38.3 -19.1
1.50 4.84d 2.76d 1.15d .61 34.4 60.9 67.4 20.9
3.00 4.85d 1.63d 1.05d .58b 35.4 64.0 70.7 23.0
6.00 4.88d I.58d 1.02d .56b 35.6 65.0 71.5 25.3
12.00 4.87d 1.62d 1.04d .58b 35.9 63.1 70.1 22.1
24.00 4.96d 1.36d .88d .48c 35.4 68.7 74.3 37.2
SE .06 .33 .31 .10
Least square means and standard error (SE).
'
' Different from ug/ml concentration (P<.05, .01, .001)
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TABLE 6. EFFECT OF IONOPHORE RO 22-6924/004 ON LACTIC ACID
CONCENTRATION FROM IN VITRO FERMENTATION OF GLUCOSE 3
Lactic acid Percent Inhibition
concentration
ug/ml
Final
pH
Total L(+)
mg/ml
W-) M-)
%
Total LM D(-)
4.23 4.91 4.27 .64 13.0 - - -
.9 4.30 4.68 3.92 .76 16.2 4.7 8.2 -18.8
.19 4.32 4.13 b 3.0l d 1.1
2
b 27.1 15.9 29.5 -75.0
.38 4.46b 3.42d 2.29d 1.13 b 33.0 30.3 46.4 -76.6
.75 4.73 b 2.07d 1.37d .70 33.8 57.8 67.9 -9.4
1.50 4.77c 1.80 d 1.16 d .64 35.6 63.3 72.8 0.0
3.00 4.81 d 1.82d 1.17d .65 35.7 62.9 72.6 -1.6
6.00 4.80d 1.77d 1.13d .64 36.2 64.0 73.5 0.0
12.00 4.89d 1.57d .98d .59 37.6 68.0 77.1 7.8
24.00 4.97d 1.26d .80d .46 36.5 74.3 81.3 28.1
SE .06 .17 .12 .13
Least square means and standard error (SE).
'
c
' Different from ug/ml concentration (P<.05, .01, .001)
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TABLE 7. EFFECT OF IONOPHORE R O 2 1 -6 4 * 7/ 9 ON LACTIC ACID
CONCENTRATION FROM IN VITRO FERMENTATION OF GLUCOSE 3
Final
PH
Lactic acid Percent Inhibition
concentration
Mg/ml
Total U+)
mg/ml
«-) W-)
%
Total L<+) D(-)
4.40 4.73 3.69 1.04 21.9 - -- -
.09 4.39 4.54 3.47 1.07 23.8 4.0 6.3 -3.7
.19 4.39 4.69 3.59 1.10 23.7 .9 3.0 -6.6
.38 4.40 4.78 3.59 1.19b 24.9 -1.1 3.0 -15.0
.75 4.47b 4.39 3.16c 1.23b 28.0 7.4 14.6 -18.5
1.50 4.68d 2.5 7d 1.62d .95 37.1 56.5 7.9 45.9
3.00 4.74d 2.06d 1.29d .77c 37.5 56.2 65.0 24.8
6.00 4.70d 2.31 d 1.43d .88b 38.0 51.1 61.1 15.2
12.00 4.71 d 2.46d 1.51 d .94 38.4 48.1 59.0 8.9
24.00 4.72d 2.50 d 1.54d .96 38.5 47.1 58.3 6.8
5E .02 .15 .13 .05
Least square means and standard error (SE).
'
c
' Different from ug/ml concentration (P<.05, .01, .001)
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TABLE S. EFFECT OF LASALOCID ON LACTIC ACID CONCENTRATION FROM IN
VITRO FERMENTATION OF GLUCOSE 3
Final
PH
Lactic acid Percent Inhibition
concentration
Hg/ml
Total U+)
mg/ml -
K-) K-)
%
Total U+) D(-)
4.28 4.79 3.99 .80 16.7 - - -
.09 4.40 3.77c 2.79d .98 26.0 21.3 30.1 -15.0
.19 4.47 3.5 3C 2.42d 1.11 31.4 25.1 39.4 -38.8
.38 4.64b 2.82d 1.95d .87 30.9 41.1 51.1 -8.8
.75 4.86d 1.91 d 1.23d .68 35.6 60.1 69.2 15.0
1.50 4.82d 1.85d 1.00d .76 41.1 61.3 72.7 5.0
3.00 4.97d 1.60d 1.04d .56 35.0 66.6 73.9 30.0
6.00 5.03d 1.35d .84d .51 37.8 71.0 79.0 48.8
12.00 5.16d 1.08d .73d .35b 32.4 77.5 81.7 56.3
2*. 00 5.24d .82d .43d .29c 47.6 82.9 89.2 63.8
SE .06 .17 .12 .13
aLeast square means and standard error (SE).
'
c
' Different from ng/ml concentration (P<.05, .01, .001)
kZ
TABLE 9. EFFECT OF MONENSIN ON LACTIC ACID CONCENTRATION FROM IN
VITRO FERMENTATION OF GLUCOSE3
Antibiotic
Final
pH
Lactic acid Percent Inhibition
concentration
Mg/ml
Total L(+)
mg/ml
«-) Total LM D(-)
4.30 4.68 3.81 .88 1S.8 - - -
.09 4.41 3.5 4C 2.50c 1.04 21.4 24.4 34.4 -18.2
.19 4.50 3.13d 2.04d 1.09 34.8 33.1 46.5 -23.9
.38 4.71 d 2.66d l.71 d .95 35.7 43.2 55.1 -8.0
.75 4.8 l d 2.38d 1.63d .75 31.5 49.1 57.2 14.8
1.50 4.82d 1.88d 1.15d .73 38.8 59.8 69.8 17.1
3.00 4.93d 1.5 2d .97d .55b 36.2 67.5 74.5 37.5
6.00 5.05d 1.43d .92d .51 b 35.7 69.4 75.9 42.1
12.00 5.07d 1.26d .75d .51 b 40.5 73.1 80.3 42.1
24.00 5.10d 1.13d .68d .45c 39.8 75.9 82.2 48.9
SE .07 .23 .18 .08
Least square means and standard error (SE).
b
'
c
' different from ug/ml concentration (PC05, .01, .001)
43
TABLE 10. EFFECT OF NARASIN ON LACTIC ACID CONCENTRATION FROM IN
VITRO FERMENTATION OF GLUCOSE3
Least square means and standard error (SE).
'
c
' Different from ug/ml concentration (P<.05, .01, .001)
Antibiotic
Final
pH
Lactic acid Percent Inhibition
concentration
Mg/ml
Total L(+)
mg/ml .
DM K-)
%
Total L(+) DM
4.25 5.87 4.74 1.13 19.2 - - -
.09 4.37 4.88b 3.5 9C 1.29 27.3 16.5 25.0 -25.0
.19 4.5 4b 3.43d 2.32d 1.11 33.2 41.5 52.0 -14.0
.38 4.82d 2.17d 1.32d .85 39.1 63.0 72.3 12.2
.75 5.02d 1.42d .86d .56b 38.8 75.9 81.5 47.0
1.50 5.03d 1.27 d .78 d .49c 38.5 78.4 83.4 50.8
3.00 5.02d 1.25d .76d .49c 39.3 78.7 83.9 50.8
6.00 5.05d 1.13 d .69d .44c 38.9 80.6 85.7 51.8
12.00 5.1 l d .94d .58d .36c 38.5 84.0 88.1 60.3
24.00 5.19d .69d .41 d .28d 41.5 88.3 91.6 70.1
SE .07
.25 .22 .16
wTABLE 11. EFFECT OF SALINOMYCIN ON LACTIC ACID CONCENTRATION FROM
IN VITRO FERMENTATION OF GLUCOSE3
Final
pH
Lactic acid Percent Inhibition
concentration
Mg/ml
Total U+)
mg/ml •
EK-) K-)
%
Total L( + ) D(-)
4.46 4.06 3.57 .49 12.1 - -- -
.09 4.48 3.57 2.75
d
.82b 22.7 9.79 20.5 -82.5
.19 4.66 3.29c 2.37 d .92c 27.5 16.9 31.1 -98.7
.38 4.95 b 1.83d 1.20 d .63 34.0 54.3 65.8 -36.5
.75 5.23d .98d .64 d .34 32.8 82.1 30.4 76.4
1.50 5.25d .94d .64d .30 31.1 76.9 82.1 37.5
3.00 5.19d .93d .62d .31 31.4 77.3 82.6 32.2
6.00 5.18d 1.01 d .68d .33 32.5 74.6 80.5 25.1
12.00 4.95b .87 d .60d .27 31.6 77.7 82.7 32.5
24. 00 4.95b .75d .50d .25 34.2 80.3 85.2 35.2
SE .13 .18 .14 .08
Least square means and standard error (SE).
'
c
' Different from ug/ml concentration (P<.05, .01, .001)
-5
TABLE 12. EFFECT OF THIOPEPTIN ON LACTIC ACID CONCENTRATION FROM IN
VITRO FERMENTATION OF GLUCOSE3
Final
PH
Lactic acid Percent Inhibition
concentration
Mg/ml
Total L(+)
mg/ml
D(-) IX-)
%
Total L(+) W-)
4.44 5.09 4.09 1.00 19.7 - — -
.09 4.58 2.93d 2.17d .76° 29.5 42.2 47.0 24.0
.19 4.7l b 1.55 d 1.06d .49d 38.2 69.7 74.5 51.0
.38 5.01 d .92d .60d .32d 35.7 81.9 85.4 68.0
.75 5.10d .91 d .59d .32d 35.1 82.2 85.6 68.0
1.50 5.13 d .83d .55d .28d 33.4 83.8 86.8 72.0
3.00 5.10 d .75d .46d .29d 40.8 85.2 88.8 70.0
6.00 5.10d .65 d .40d .25d 39.8 87.3 90.4 75.0
12.00 5.14d .74d .47d .27d 34.7 85.4 88.5 73.0
24.00 5.09d .56d .36d .20d 37.8 89.1 91.4 80.0
SE
.08 .29 .27 .06
Least square means and standard error (SE).
b, c, d
Different from ug/ml concentration (P<.05, .01, .001)
^6
TABLE 13. EFFECT OF TYLOSIN ON LACTIC ACID CONCENTRATION FROM IN
VITRO FERMENTATION OF GLUCOSE3
Final
pH
Lactic acid Percent Inhibition
concentration
Mg/ml
Total L(+)
mg/ml
DM D(-)
%
Total L(+) D(-)
4.36 4.70 3.77 .93 19.7 - - -
.09 4.36 4.43 3.40 1.03 23.6 3.5 7.7 -11.7
.19 4.60b 3.36c 2.40d 0.96 29.8 29.1 36.5 -5.7
.38 4.84d 1.87d 1.27d .60b 31.1 59.9 65.6 36.3
.75 4.9 l d 1.69d 1.14d .55 c 31.7 62.9 68.3 41.9
1.50 5.00d 1.56d 1.09d .47d 34.5 64.5 69.9 47.9
3.00 5.17d .79d 0.47d .32d 46.6 82.9 87.0 64.0
6.00 5.29d .46d 0.20d .26d 60.4 90.4 95.1 69.4
12.00 5.31 d .45 d 0.1 5d .30d 68.7 90.4 96.0 65.1
24.00 5.36d .38d 0.1 l d .28d 74.7 91.9 97.4 67.3
SE .08 .36 .26 .09
Least square means and standard error (SE).
b
>
c
> different from ng/ml concentration (P<.05, .01, .001)
^7
TABLE 1*. EFFECT OF VIRGIN1AMYCIN ON LACTIC ACID CONCENTRATION FROM
IN VITRO FERMENTATION OF GLUCOSE3
Antibiotic
Final
PH
Lactic acid Percent Inhibition
concentration
Mg/ml
Total L(+)
mg/ml
W-) D(-)
%
Total U+) W-)
4.23 5.01 4.14 .87 17.2 - - -
.09 4.31 4.20b 3.12d 1.08 25.9 15.1 24.9 -31.7
.19 4.67 d 2.09d 1.45 d .64 29.8 58.1 65.2 19.9
.38 4.94d
.83d .63d .20d 26.5 83.3 85.0 74.1
.75 4.94d .94d .65 d .29 d 32.1 81.1 84.6 62.3
1.50 5.00d .85d .55d .30d 37.3 82.9 87.1 57.1
3.00 5.08d .64d .41 d .23d 40.1 87.0 90.3 66.3
6.00 5.20d .46d .27d .19d 45.5 90.8 93.7 72.5
12.00 5.65d .40d .17d .23d 52.5 91.8 95.9 67.4
24.00 5.94d .36d .20d .16d 44.7 93.0 95.1 82.6
SE .05 .19 .11 .12
Least square means and standard error (SE).
'
c
' Different from ug/ml concentration (P<.05, .01, .001).
1*8
TABLE 15. EFFECT OF MONENSIN AND TYLOSIN ON LACTIC ACID
CONCENTRATION FROM IN VITRO FERMENTATION OF GLUCOSE3 '"
Monensin and tylosin were added at 3:1 ratio.
Least square means and standard error (SE).
'
'
e
Different from ug/ml concentration (P<.05, .01, .001)
Antibiotic
Final
pH
Lactic acid Percent Inhibition
concentration
Mg/ml
Total L(+)
mg/ml
rx-) rx-)
%
Total LW rx-)
4.29 5.44 4.51 .93 16.8 - -- -
.09 4.38 4.94 4.04 .90 18.4 8.7 10.3 3.5
.19 4.40 4.38c 3.27d 1.21 c 26.7 17.7 27.5 -34.4
.38 4.88e 2.01 e 1.27e .74 34.6 63.7 71.7 26.0
.75 4.97e 1.54e 1.01e .53c 32.3 72.4 77.6 46.7
1.50 5.15e l.Il e .68e .43e 37.1 80.3 84.7 60.2
3.00 5.10e 1.05e .65e .40e 37.0 81.4 85.4 63.1
6.00 5.14e .95e .54e .41 e 39.0 83.2 87.9 60.1
12.00 5.26e .60e .29e .31 e 51.7 89.4 93.5 66.4
24.00 5.35e .38e .10e .28e 78.9 93.1 97.6 68.9
SE
.08 .24 .23 .09
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monensin (table 16), although IC50 for L(+) lactic acid was slightly lower for
monensin than lasalocid. Among the nonionophore compounds avoparcin was the
least effective compound in inhibiting lactic acid. Thiopeptin, virginiamycin and
tylosin were extremely effective in inhibiting lactic acid production. The extent
of inhibition of total lactic acid was almost 90 to 95% at the highest concentration
(2<f.O ug/ml) with thiopeptin, tylosin and virginiamycin. Among the compounds
tested, thiopeptin and virginiamycin seemed to be the most effective inhibitors of
lactic acid production from glucose fermentation. Monensin and tylosin combination
(3:1) were more effective than monensin alone but not different from tylosin alone
in inhibiting lactic acid production (table 6).
Effects of incubation time and salinomycin concentration on VFA production
Total VFA concentration increased progressively (P<.05) with increased incubation
time in both control (no antibiotic) and salinomycin-treated fermentations (table
17). The molar proportion of acetate in the control fermentation was higher (P<.05)
at 6 h incubation than at 12, 18 or 2k h incubation. Incubation time had no effect
on the molar proportions of propionate and isobutyrate and acetate: propionate
ratio in the control fermentation. However, molar proportions of butyrate and
valerate at 2H h were higher than that of the 18, 12 and 6 h incubations (P<.05)
and that of isovalerate was higher at 24 and 18 h (PC05) than at 12 and 6 h
incubations (table 17). Addition of salinomycin to the fermentation had no effect
on the total VFA concentration at all incubation time. However, final pH of the
fermentation mixture tended to be lower in salinomycin-treated fermentations than
the control. Molar proportions of VFA except that of isobutyrate and butyrate
were unaffected by the addition of salinomycin at 6 h incubation.
Salinomycin-treated fermentations incubated for 12 h or longer generally had lower
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proportions of acetate and butyrate and higher proportion of propionate than the
control. Also molar proportions of isobutyrate, isovalerate and valerate were not
affected by salinomycin except for slight increase in isobutyrate and isovalerate at
24 h incubation. Salinomycin-treated fermentations incubated for 12 h or longer
had lower acetate:propionate ratio at all concentrations than the control (table
17). The extent of propionate enhancement, butyrate and acetate:propionate ratio
inhibition in fermentations incubated for 12 h or longer by salinomycin was similar
(table 17). However, EC25 for propionate was lowest at 12 h incubation (table 18).
Effects of rumen fluid inoculum source and salinomycin concentration on
VFA production
.
Final pH of the fermentation mixture was unaffected by the
rumen inoculum source, although total VFA concentration tended to be higher with
rumen fluid inoculum collected from high-grain fed than medium- or low-grain fed
cattle (table 19). Also, rumen fluid inoculum source had no effect on the molar
proportions of individual VFA in the control fermentations. Addition of salinomycin
had no effect on total VFA concentration. However, final pH of the
salinomycin-treated fermentation tended to be lower than that of the control.
Salinomycin decreased the molar proportion of acetate only at 2* and 48.0 ug/ml
concentrations in fermentations with rumen fluid inoculum from cattle fed
high-grain diet. Molar proportion of propionate increased in fermentations treated
with salinomycin. Accordingly, acetate:propionate ratio was lower in salinomycin-
treated fermentations than the control. The extent of propionate enhancement and
acetate:propionate ratio reduction was highest in fermentations with rumen fluid
inoculum from cattle fed low-grain diet and lowest in fermentations with rumen
fluid inoculum from cattle fed high-grain diet (table 19). EC 25 for propionate in
fermentations with rumen fluid from low-grain fed cattle was lower than in the
53
TABLE 18. EFFECT OF INCUBATION TIME ON PROPIONATE ENHANCEMENT
BUTYRATE INHIBITION AND ACETATE-PROPIONATE RATIO REDUCTION
BY SALINOMYCIN.
Incubation
time, h
Propionate
enhancement
EC25,a ug/ml
Butyrate
inhibition
IC25, ug/ml
Acetate-propionate
ratio reduction
IC25,
D
ug/ml
6 >48.00 >48.00 >48.00
12 4.00 >48.00 5.46
IS 10.26 >48.00 9.78
24 9.91 >48.00 7.46
Salinomycin concentration required to enhance propionate by 25% of the control
Salinomycin concentration required to reduce butyrate or acetate-propionate ratio by
25* of the control.
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fermentation with rumen fluid from cattle fed 50* grain diet (table 20). However,
IC25 for acetate: propionate ratio was similar in fermentations with rumen fluid
from cattle fed low-grain or medium-grain diet. Salinomycin addition lowered
(P<.05) the molar proportion of butyrate in fermentations with rumen fluid inocula
from cattle fed low- or medium-grain diet but not in fermentations with rumen
fluid from high-grain fed cattle (table 20). Molar proportions of isobutyrate,
isovalerate and valerate were unaffected by either rumen fluid inoculum source or
salinomycin.
Effects of antimicrobial compounds on VFA production. Total VFA
concentration was unaffected by the addition of the antimicrobial compounds
(tables 21 to 31) except that of RO22-6924/004, tylosin and virginiamycin which
caused a reduction (P<.05) at 24.0 ug/ml concentration (tables 22, 29 and 30).
Occassionally, total VFA concentrations were higher in antibiotic treated
fermentations than the control. The acetate proportion was not affected by
avoparcin, RO22-6924/00<>, RO21-6W/009, lasalocid, monensin, narasin and
salinomycin. However, tylosin, monensin and tylosin combination, thiopeptin and
virginiamycin increased (P<.05) the molar proportion of acetate at 6 ug/ml or
higher concentrations (tables 28 to 31). Avoparcin, RO22-6924/004,
RO21-6W/009, lasalocid, monensin, narasin, salinomycin and thiopeptin increased
the molar proportion of propionate. In most instances the increase was significant
at concentrations greater than .75 ug/ml- Tylosin and virginiamycin at low
concentrations (.75-3.0 pg/ml) increased (P<.05) and at high concentrations (> 6.0
ug/ml) decreased (P<.05) the molar proportion of propionate (tables 29 and 30).
Monensin and tylosin combination had no effect on propionate proportion (table
31). Narasin and salinomycin appeared to be the most effective among the
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TABLE 20. EFFECT OF RUMEN FLUID INOCULUM SOURCE ON PROPIONATE
ENHANCEMENT, BUTYRATE INHIBITION AND ACETATE-PROPIONATE
RATIO REDUCTION BY SALINOMYCIN.
Rumen Fluid
inoculum
source
Propionate
enhancement
EC25, ug/ml
Butyrate
Inhibition
IC25,
D
Mg/ml
Acetate-Propionate
ratio reduction
IC25,
D
Mg/ml
20* grain diet 3.43 1.34 11.27
50% grain diet 2.42 2.95 2.74
80% grain diet >48.00 >48.00 32.00
Salinomycin concentration required to enhance propionate by 25% of the control
Salinomycin concentration required to reduce butyrate or acetate-propionate ratio by
25% of the control
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compounds tested and lasalocid was more effective than monensin in enhancing
propionate. Acetate:propionate ratio tended to be lower in antibiotic-tested
fermentations than the control. Tylosin and virginiamycin increased (P<.05)
acetate:propionate ratio at high concentrations (24 or 48.0 ug/ml). Based on IC25
for acetate:propionate ratio, salinomycin appeared to be the most potent of all the
antibiotics. The molar proportion of butyrate was reduced (P<.05) by all the
antimicrobial compounds even at the lowest concentration tested (.75 ug/ml). In
general, ionophore antibiotics were more inhibitory to butyrate production than the
nonionophore antibiotics (table 32). Molar proportions of isobutyrate, isovalerate
and valerate were not affected by the addition of antimicrobial compounds.
Discussion
Because of the wide acceptance of lasalocid and monensin in the cattle
industry, several antimicrobial compounds are being investigated as possible feed
additives (Chalupa, 1984). Among the ionophore antibiotics, RO22-6924/004, narasin
and salinomycin have shown excellent promise and are reportedly more potent than
lasalocid or monensin for improving feed efficiency and rate of gain of feedlot
cattle (Dinusson et al., 1979; Potter et al., 1979; Thonney et al., 1983; Merchen
and Berger, 1985). Avoparcin, a glycopeptide antibiotic (McGahren et al., 1980) has
been shown to be similar to monensin in its effect on the performance of finishing
cattle (Johnson et al., 1979; Dyer et al., 1980; Cuthbert et al., 1984). Thiopetin, a
sulfur containing peptide (Miyairi et al., 1972) is an effective inhibitor of S. bovis
(Muir and Barreto, 1979) and therefore, effective in controlling lactic acidosis in
cattle (Muir et al., 1980). Thiopeptin supplementation of a high-concentrate diet
(II ppm) increased weight gain and feed efficiency (Gill et al., 1979). Improved
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performance of tylosin fed cattle is generally attributed to its ability to prevent
liver abscesses (Potter et al., 1985). Virginiamycin, a growth-promoting antibiotic
used in pigs has also been shown to have growth-promotion effect in cattle
(Demeyer and VanNevel, 1985).
Improvement in efficiency of feed utilization in lasalocid- or monensin-fed
cattle is attributed to favorable alterations in rumen fermentation characteristics
(Bartley and Nagaraja, 1982; Bergen and Bates, 1984; Schelling, 1984). The
mechanisms by which lasalocid and monensin alter fermentation characteristics are
believed to be due to shift in the rumen microbial community. Bacteria that
produce lactic, butyric, formic and H
2 are very sensitive, whereas, succinate
producing and lactate-fermenting bacteria are resistant, thereby, resulting in a
bacterial community that produces less lactic, less butyric, less methane and more
propionic acid (Chen and Wolin, 1979; Dennis et al., 1981b).
Rumen fermentation changes induced by many of the antimicrobial
compounds have been shown to be similar to that of monensin and lasalocid in that
acetaterpropionate ratio is decreased, lactic acid production is inhibited,
methanogenesis is depressed and ruminal degredation of protein and amino acids is
lowered (Dyer et al., 1979; Muir et al., 1980; Froetschel et al., 1983; DeMeyer and
Van Nevel, 1985; Merchen and Berger, 1985; Nagaraja et al., 1985). Also,
sensitivity and resistance of rumen bacteria to the various antimicrobial compounds
used in the study were very similar to lasalocid and monensin in that gram positive
bacteria are resistant and gram negative bacteria are sensitive (Akkad and Hobson,
1966; Wang et al., 1966; Fulghum et al., 1968; Watanabe et al., 1981; Stewart et
al., 1983, Taylor and Nagaraja, manuscript submitted for publication). Avoparcin
and tylosin have been shown to be less inhibitory to the two major gram positive
lactic acid producing bacteria (Streptococcus bovis and lactobacillus sp.) (Walton,
1978; Dutta and DeVriese, 1981; Taylor and Nagaraja manuscript submitted for
publication). However, both avoparcin and tylosin were very effective in inhibiting
lactic acid production from glucose fermentation in the in vitro system. In fact,
tylosin was more effective in inhibiting lactic acid production than the ionophore
antibiotics and the latter are more inhibitory to S. bovis and lactobacilli than the
former. This is difficult to explain but it could be speculated that tylosin in a
mixed culture fermentation may get metabolised and the metabolite may be more
inhibitory to the lactic acid producing bacteria than the parent compound. Among
the ionophore compounds narasin and salinomycin were more effective in inhibiting
lactic acid production than lasalocid and monensin. This is in agreement with our
previous report that salinomycin at .22 mg/kg body weight was as effective as
lasalocid or monensin at .66 mg/kg in preventing experimentally induced lactic
acidosis in cattle (Nagaraja et al., 1985).
Narasin and salinomycin also were more potent in enhancing propionate
production and reducing acetate:propionate ratio than lasalocid and monensin. A
similar difference in efficacy has also been observed in feedlot performance
studies. The optimum dosage for narasin and salinomycin is about 3-fold less than
that of lasalocid and monensin (Dinusson et al., 1979; Potter et al., 1979; Merchen
and Berger, 1985). It is interesting that tylosin's effect on VFA production was
antagonistic to that of monensin. Tylosin lowered propionate production and
increased acetate production. Consequently, combination of monensin and tylosin
(3:1) had no effect on acetatetpropionate ratio at the recommended dosage level
(assuming 6 ug/ml represents ruminal concentration of monensin and tylosin in
cattle fed at 30 g and 10 g/ton, respectively). However, Potter et al. (1985) based
on the summary of 14 feedlot trials demonstrated additive effects of monensin and
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tylosin. Liver abscess control, along with improvements in daily gain and feed
efficiency were obtained by the addition of tylosin to monensin-containing diets.
In conclusion, in vitro quantitative evaluation, based on propionate
enhancement, acetate:propionate ratio reduction and lactic acid inhibition may be
used as a screening method to predict the feed additive potential of the
antimicrobial compounds.
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INTRODUCTION
Antimicrobial agents are used not only for the control and treatment of
bacterial and parasitic diseases, but also for the enhancement of body growth and
the improvement of feed efficiency. The discovery in the late 19Ws that feeding
chlortetracycline to chicks enhanced their growth rate marked the beginning of the
large scale use of antibiotics in animal feeds. Antibiotics as feed additives have
been used commercially in animal feed for improving weight gain and feed
efficiency for almost thirty-five years (Silver and Mercer, 1978). In the United
States alone, more than one million kg. of antibiotics are used annually as diet
supplements (Hays, 1978). Forty percent of the antibiotics sold are for
non-medicinal use. This wide acceptance of feed additives can be attributed to
their ability to improve growth and feed efficiency, and reduce mortality and
morbidity from clinical and subclinical infections.
Some of the more commonly used antibiotics in livestock production include
bacitracin, bambermycin, chlortetracycline, erythromycin, hygromycin, lasalocid,
lincomycin, monensin, neomycin, novobiocin, nystatin, oxytetracycline, penicillin,
streptomycin, tylosin, and virginiamycin (table 1). Other antibiotics which
experimentally show promise await further testing and possible approval.
MECHANISM OF ACTION
The mechanism in which antibiotics improve growth is not fully understood.
At least three general modes of action have been postulated (Hayes, 1978). A) a
metabolic effect, in which the antibiotics directly affect the rate or pattern of
the metaboolic processes of the animal. B) a nutrient-sparing effect in which the
antibiotics reduce the dietary requirement for certain nutrients by stimulating the
growth of desirable organisms that synthesize vitamins or amino acids, by
£0
TABLE 1. ANTIMICROBIAL AGENTS APPROVED FOR USE IN FOOD ANIMALS
Antibiotic
Trade
name
Approved usage
^^^
cattle sheep swine chicken
Bacitracin
methylene
disaiicylate
BMD*
Fortracina
Solutracin3
M F,G,M E,F,G,M
Bacitracin zinc Albaca
Bacifernc
Zinc-
Bacitracinc
F,G F,G F,G
Bambermycins Flavomycin F,G C,F,G
Chlortetracyciine Aurepmycine
CTC*.
CLTCg
.
Chloratet"
Pfichlor'
F,G,M F,G,M F,G,M C,F,G,M
Erythromycin Gailimycin* F,G F,G E,F,G,M
Hygromycin B Hygromix A A
Lasaiocid Avatec'
Bovatec
F>G C C
Lincomycin Lincomixm M C,F,G,M
Monensin Coban k
,
.
Rumensin
F,G
Neomycin Neomycin
sulfate'
Neomix"1
M M M M
Novobiocin Albamixm M
Nystatin Myco-20 n M
OxytetracycJine Terramycin 1
OXTC*
F,G,M F,G,M F,G,M E,C,F,
G,M
Penicillin Penicillin P-100 1
Procaine Penicillin"
F,G F,G,M
Saiinomycin Biocox
c
Streptomycin
Tyiosin
Virginiamycin
Strepciliin F-25c
Tylank
Stafacs
M
F,G,M
F,G,M
F,G,M
E,F,G,M
F,G,M
F,G
C
-
Growth, M
. M^rSTEESM •VSfSSo' ' * Fttd "***»
ftmicaf? "?
r
^rre^u,e
n8
!N
W0
^,^
f'S
', S ! """-"«"»-' Minerals and
f
SDS Biotech Corp., Pamesviiu OH- «*»*? £ c^"«n"d Co., Wayne, NJ;
*...->.
-»T*EI_ ._"-""' °H; "mith iJ}|nei_.An'™ 1 Health Products,
k, NY;
lapolis,
Squibb
Westchester PA-^Hms and r,;!' . 7 / im,, KU 1 imal
'Ceva^£J%£%^^»^^™»* Inc..New York
IN; Wfmann-LaRoche Inc., Nut"? nT^Un^^K^""' C°- nIndianaP
and Sons, Princeton. tt ^JES^S J5S5JS" ffiamaroo, MI; rtE.R. ,bl, NJ; °Agri-Bio Corp., Gainesville, GA.
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depressing the organisms that compete with the host for nutrients, by increasing
the availability of nutrients via chelation mechanisms, or by improving the
absorptive capacity of the intestinal tract. C) A disease control effect by
suppressing organisms causing clinical or subclinical disease, by inhibition of
multiplication of organisms that produce toxins which reduce performance but
result in no obvious disease symptoms.
A. Metabolic effect. There is evidence that metabolic reactions in the host are
influenced by antibiotics. Brody et al. (1954) found that tetracyclines inhibit fatty
acid oxidation in the mitochondria. Braude and Johnson (1953) discovered the use
of chlortetracycline affected water and nitrogen excretion, and correlated this to
the metabolic rate of pigs. Hash et al. (1964) demonstrated the inhibition of
protein synthesis in the presence of tetracycline. Although it is apparent that some
alterations in metabolism do occur, it is unlikely that the metabolic effects alone
could account for the growth promotion in animals.
B
-
Nutrient sparing effect. It is recognized that certain organisms synthesize
vitamins and amino acids which are essential to the host animal, while other
organisms compete with the host for these same essential nutrients. Anderson et
al. (1952) discovered an increase in the numbers of intestinal coliforms other than
Escherichia coli when animals were fed penicillin. These organisms synthesize
nutrients which are dietary essentials for the host. Therefore, a diet that is
deficient in vitamins or nutrients may be partly corrected by microbial synthesis
following a shift in microbial population induced by antibiotics, resulting in
improved gain and/or efficiency.
Lucas (1957), Stokstad (1954) and others have indicated a greater response
to antibiotics when included in an inadequate diet. This enhanced response may
e-
also be attributed to a reduction in the population of organisms which compete
with the host for essential nutrients, particularly those nutrients close to or below
the animals requirements. Lactobacilli require amino acids in proportions similar to
that of a growing pig (Kellogg et al., 196*). Antibiotics most effective in reducing
the population of Lactobacilli in the intestinal tract are the most effective growth
promotors in growing pigs (Kellogg et al., 1966).
An increase in the absorptive capacities of the gut of the host animal also
may aid in growth promotion. Braude et al. (1955) discovered a thinner gut wall in
pigs fed antibiotic than those receiving no antibiotic. Rusoff et al. (195*) and
Coates (1953) reported similar findings in calves and chicks. A thinner intestinal
wall implies potential for improved absorption with a resulting increase in the
utilization of nutrients. This was exemplified by Catron et al. (1953) who reported
an increase in the rate of glucose absorption in animals fed diets containing
antibiotics.
C
-
Disease control effect. Early in the history of antibiotic usage, it was
discovered that the general well being of the animal was inversly proportional to
the response one received from antibiotic addition. Speer et al. (1950) noted that
healthy, well nourished pigs did not respond to antibiotics when housed in clean
and disinfected pens. Studies indicate a greater response to antibiotics in
contaminated environments than those housed in clean environments. Hays and
Speer (1960) found that pigs in a clean environment had a 33* improvement in gain
and a 10.5% improvement in feed efficiency when supplemented with spiramcyin.
Pigs in an uncleaned building were also fed spiramycin with a resulting 75%
increase in growth rate and a 37% improvement in feed conversion. Similar results
were obtained for chlortetracycline and oxytetracycline. The addition of
antibiotics to feed acted to reduce the buildup of nonspecific infection in the
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uncleaned pens, resulting in a greater improvement in performance with respect to
the clean and disinfected pens.
ANTIMICROIBAL FEED ADDITIVES FOR RUMINANTS
A major distinction between ruminant and nonruminant animals is the
possession by ruminants of a modified forestomach or rumen, specifically adapted
to the microbial digestion of feed. The rumen is inhabited by many microorganisms
that carry out fermentation of complex polysaccharides and proteins, producing
volatile fatty acids and microbial protein which in turn serve as the nutrients for
the metabolism of the host. Fermentative digestion by microorganisms in the rumen
is advantageous for substances that cannot be digested by the animals own
hydrolytic enzymes. However, microbial fermentation of dietary protein, starch and
sugars and products of fermentation such as sugars and amino acids is accompanied
by losses in both energy and animal nitrogen. Therefore, for optimal production a
proper balance between microbial fermentation and hydrolytic digestion is
desirable.
In order to maximize the efficiency of feed utilization in ruminants,
research in the past decade has been focussed towards chemicals which promote
adjustments in ruminal fermentation to decrease losses in energy and nitrogen and
improve animal performance (Chalupa, 1977). Such manipulation should not affect
the beneficial aspect of microbial digestion such as fiber degradation and microbial
protein synthesis from nonprotein nitrogen. Modifying rumen microorganisms can
alter efficiency of animal performance in several ways (Owens et al., 198*).
Chemical agents may: (1) Alter the levels of normal metabolites (2) Prevent
accumulation of abnormal compounds (3) Inhibit catabolism of specific nutrients.
Most chemicals were initially identified as adjustors of specific
fermentation pathways such as propionate, methane, or lactate production, amino
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acid utilization or urea hydrolysis, but later it became apparent that control of
selected fermentative pathways was not as specific as originally hypothesized
(Chalupa, 1979).
The most widely researched chemical is a polyether antibiotic called
monensin which has been shown to alter rumen fermentation to improve cattle
performance. Monensin was first approved as a feed additive for feedlot cattle in
1976, and by 1978 over 80* ofthe cattle in feedlots were being fed monensin. Such
rapid acceptance led to the introduction of another polyether antibiotic called
lasalocid sodium in 1982. The monensin and lasalocid success story has stimulated
testing of other ionophore and nonionophore antibiotics which alter rumen
fermentation. Currently the following antibiotics have received attention as
potential feed additives for cattle: actaplanin, avoparcin, laidlomycin, lysocellin,
narasin, salinomycin, thiopeptin, and virginiamycin (table 2).
MONENSIN
Monensin is a monocarboxylic acid polyether ionophore (Fig 1) produced by
Streptomyces cinnamonensis (Haney and Hoehm, 1968). It was the first polyether
antibiotic to be structurally defined (Agtarap and Chamberlin, 1967). The cation
selectivity has been determined to be Na+ » K+> >Rb+ > Li+ > Cs+ (Westley,
1982). The antibiotic possesses broad spectrum anticoccidial activity in chickens
and is marketed as a coccidiostat under the trade name CobanR (Elanco Products
Co., Indianapolis, IN). Monensin is highly effective against gram positive bacteria,
but exhibits no activity against gram negative bacteria (Watanabe et al., 1981;
Westley, 1982). It is believed that feeding monensin alters rumen microbial
population causing a beneficial shift in fermentation, thus enhancing the feed
efficiency (Bergen and Bates, 1984). Monensin, marketed under the trade name
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TABLE 2. ANTIMICROBIAL FEED ADDITIVES UNDER INVESTIGATION FOR USE
IN CATTLE
Antibiotics
Producing
organism Chemistry Company
Actaplanin
Avoparcin
Laidlomycin
Lysocellin
Narasin
Salinomycin
Thiopeptin
Virginiamycinc
Actinoplanes
missouriensis
Streptomyces
candidus
Streptomyces
eurocidicus var
asterocidicus
Streptomyces
longwoodensis
Streptomyces
aureofaciens
Streptomyces
albus
Streptomyces
tateyamensis
Streptomyces
virginiae
Glycopeptide
Glycopeptide
Polyether
ionophore
Polyether
ionophore
Polyether
ionophore
Polyether
ionophore
Peptide
Macrocyclic
lactone
peptolide
Eli Lilly Co.,
Indianapolis, IN
American Cyanamid
Co., Wayne, NJ
Syntex, Palo
Alto, CA
International
Minerals Corp.,
Terre Haute, IN
Eli Lilly Co.,
Indianapolis, IN
A.H. Robins Co.,
Richmond, VA
Fujisawa Pharm-
aceutical Co.,
Osaka, Japan
Smith Kline Animal
Health Products,
Westchester, PA
Approved (trade name Avotan) for use as a growth promotor in animals in Europe
Approved (trade name Bio-Cox) for use as a corcidiostat in chickens
c
Approved (trade name Stafac) for use as a growth promotor in chickens and
swine.
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Figure 1. Structure of Konensin
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Rumensin (Elanco Products Co., Indianapolis, IN) has been used extensively in
feedlot cattle since 1975 with a great deal of success.
Influence on cattle performance
. Since its use in feedlot diets began,
monensin has gained wide acceptance in the cattle feeding industry. Numerous
experiments have been conducted to evaluate the influence of monensin on
performance of feedlot cattle. A summary of 228 trials involving 11,274 head of
cattle fed control or monensin-containing diets has been compiled (Goodrich et al.,
1984). Cattle fed monensin gained 1.6* faster, consumed 6.4* less feed, and
required 7.5* less feed/100 kg gain than cattle fed control diets (table 3). Carcass
characteristics were not significantly influenced by monensin. Responses of cattle
to monensin and implants were additive. When fed to beef cows, monensin reduced
amounts of feed required to maintain cow weight. The factors that may modify
these responses are not fully understood, but several synergistic modes of action
have been postulated.
Influence on feed intake
. The influence of monensin on feed intake is well
documented (Goodrich et al., 1984; Schelling, 1984). The feed intake depression due
to monensin when high grain diets are fed averages 10.7* over a wide range of
conditions (Anonymous, 1975a). This average includes the initial depression of as
much as 16* when cattle are first exposed to monensin. Realistic feed intake
depressions for high grain-fed cattle adapted to monensin would likely be 5-6*
(Owens, 1980). The depression for moderate level roughage diets appears to be
about 3* (Anonymous, 1975a). Gains are not depressed with high or moderate
levels of highly fermentable carbohydrates, and an improvement in feed conversion
results. Cattle receiving monensin under pasture conditions may be consuming up to
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TABLE 3. EFFECT OF MONENSIN ON CATTLE PERFORMANCE 3
Item Control Monensin*3 Percent change
No. of cattle
Initial weight, kg
Final weight, kg
Daily gain, kg 1.09 1. 10 1.6
Daily feed intake, kg 8.27 7.73
_6^
Feed/kg gain, kg DM 8.09 7.43
-7.5
5,696 5,578
284 283
430 432
Summary of 228 trials, Goodrich et al., 1984. Mean monensin dose was 246
head.
mg per
So
15% more forage (Pond and Ellis, 1981), with an increase in the rate of gain up to
17% (Anonymous, 1975b).
Effect of rumen bacteria. The basic mode of action of monensin and other
ionophores is to modify the movement of ions across biological membranes. The
primary result is the entry of sodium into the cells (Smith and Rosengart, 1978).
Other secondary cellular ion changes may also occur (Schanne et al., 1979).
These ion changes cause an alteration in rumen fermentation in part by
shifting the microbial flora. Chen and Wolin (1979) have studied the effects of
monensin on the growth of methanogenic and rumen saccharolytic bacteria.
Ruminococcus albus, R. flavefaciens
.
and Butyrivibrio fibrisolvens
, the major
formate and hydrogen producers, were inhibited by 2.5 ug/ml of monensin.
Bacteroides succinogenes and B. ruminicola were resistent to monensin at 20 ug/ml,
but growth was delayed. Selenomonas ruminantium was resistant to 40 ug/ml of
monensin. Among the methane bacteria, monensin inhibited Methanobacterium MOH,
M. formicium and M. barkeri
,
but Methanobrevibacter ruminantium was resistant to
monensin. It was proposed that monensin may act in the rumen by suppressing the
population of gram-positive bacteria which ferment carbohydrates to hydrogen and
formate, or to acetate and butyrate, and selecting for antibiotic resistant gram-
negative bacteria which produce succinate or produce propionate from succinate.
Similar findings have been reported by other workers. Henderson et al.
(1981) reported B. ruminicola, S. ruminantium
, Anaerovibria lipolytica and
Megasphaera elsdenii, succinate- and propionate-producing rumen bacteria, were
not affected by monensin up to 10 ug/ml. M. ruminantium was slightly inhibited by
monensin, with B. fibrisolvens, R. albus and Streptococcus bovis being inhibited to
different extents at concentrations ranging from 0.1 to 10 ug/ml. B. succinogenes
showed a delayed growth in the presence of monensin.
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Dennis et al (1981a) reported monensin inhibited B. fibnsolvens,
Eubactenum cellulosolvens
.
E. ruminantium
, Lachnospira multiparus
, Lactobacillus
ruminis, L
-
vitulinus
.
R. albus, R. flavefaciens. and S. bovis the major lactate
producing rumen bacteria. B. suconogenes
, B. ruminicola, S. ruminantium
,
Succinimonas amylolytica and Succinivibrio dextrinosolvens
. which produce
succinate as a major end product were not inhibited by monensin. Anaerovibrio
lipolytica. S. ruminantium
.
M. elsdenii and Veillonella alcalescens the major lactate
utilizers, were not inhibited by monensin. These results suggest that monensin acts
in the rumen by selecting for succinate-producing and lactate-fermentating
bacteria, and inhibiting those bacteria which produce lactate. This selection could
in part lead to the decreased acetate to propionate ratio. Methane production in
the rumen could be depressed through the inhibition of hydrogen and formate
producers, eg., R. albus, R. flavefaciens
, and L. multiparus. Dawson and Boling
(1984) reported that inhibition of B. ruminicola by monensin was greatly influenced
by the mineral content of the medium. All strains of B. ruminicola tested were
more sensitive to monensin in medium containing low concentrations of potassium.
Similar effects were observed with R. albus, R. flavefaciens, B. fibnsolvens and B.
suconogenes.
There is very little information on the effects of monensin on the
composition of the microbial population in the rumen. Brulla and Bryant (1980)
have shown increased proportions of Bacteroides species and a decreased
proportion of monensin-sensitive Butyrivibrio fibrisolvens in the rumen of cattle
fed monensin. Dawson and Boling (1983) monitored total and monensin-resistant
anaerobic bacterial populations in the rumens of steers fed monensin containing (33
mg/kg) and unmedicated diets. The mean percentage of anaerobic population
resistant to monensin (10 ug/ml) was greater in animals fed monensin supplemented
diet for 33 days than in those receiving the control diet. However, the greater
r-l
proportions of monensin-resistant organisms were not necessarily associated with
altered fermentation patterns. It was suggested that the selection of monensin-
resistant microbial groups within the rumen cannot completely account for changes
in ruminal fermentations.
Effect on rumen protozoa. Because monensin is a coccidiostat (Ruff, 1982)
it is likely that protozoal population in the rumen is affected. Dinius et al. (1976)
reported that monensin did not change protozoal numbers or types in growing
cattle fed orchard grass. Richardson et al. (1978) found that protozoal populations
in the rumen were reduced by feeding monensin to cattle on a high-grain diet but
not on a high-roughage diet. Reduction in rumen protozoal population has been
reported to be greater in cattle on urea than on a natural protein as dietary
nitrogen source (Poos et al., 1979). Such a dietary influence on the effect of
monensin on protozoa is suggestive of differing sensitivity of protozoal types to
the antibiotic. Dennis et al. (1981b) have reported entodiniomorphs particularly
Ophryoscolex, Entodimum and Diplodmium were more sensitive to monensin than
the holotrichs.
Several rumen fermentation changes have been well documented which more
directly cause the animal performance response normally observed when the
ruminants are fed monensin.
Decreased acetate:propionate ratio. Early research with monensin clearly
demonstrated a decrease in the acetate to propionate ratio (Richardson et al.,
1976). This ratio change presumes propionate is produced at the expense of acetate
(Van Maanen et al., 1978) and butyrate (Richardson et al., 1976). This ratio shift is
viewed as favorable for ruminants because propionate production by rumen
fermentation appears to be more efficient than that of acetate (Hungate, 1966;
Q2
Chalupa, 1977). A second possible factor is evidence of propionate being utilized
more efficiently than acetate by the tissue (Smith, 1971). A third possible
advantage of propionate is its flexibility as an energy source. Propionate has the
potential to be used for gluconeogenesis or be directly oxidized by the citric acid
cycle. This additional substrate for glycolysis may provide energetic advantages to
the ruminant by generating more reduced coenzyme outside the mitochondrial
membrane (Schelling, 198*).
The advantageous shift in the propionate to acetate ratio can partially be
attributed to definite changes in the microbial population and/or microbial
metabolism in response to monensin. Monensin has been found to inhibit acetate
producing bacteria, but not succinate-producing and propionate-producing bacteria
(Chen and Wolin, 1979; Dennis et ai., 1981a). The net effect would be a decrease
in acetate production with a corresponding increase in propionate production.
Control of lactic acidosis
. Research indicates that monensin may aid in the
prevention of lactic acidosis. Lactic acidosis in cattle stems from an increase in
lactic acid in rumen fluid and blood following overconsumption of highly
fermentable carbohydrates such as grains (Dunlop and Hammond, 1965; MacKenzie,
1967; Dunlop, 1972). Cattle are most susceptible to acidosis following abrupt shifts
in diet from roughage to concentrate, or when stress temporarily reduces feed
intake so that abnormally high intake results (Elam, 1976). The result is an
accumulation of lactic acid in rumen fluid and blood, which produces clinical signs
of acidosis such as diarrhea, anorexia, dullness, hyperventilation, dehydration and
death.
Rumen and blood lactic acid levels increase in unadapted cattle on high
concentrate diets because Streptococcus bovis initially proliferates and produces
lactic acid. The resulting drop in pH enhances for the growth of Lactobacilli
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species (Dunlop, 1972). Therefore, a logical approach to controlling acidosis is to
prevent proliferation of S. bovis. Dennis et al. (1981a) have demonstrated the
inhibition of S. bovis and Lactobacilli sp. by monensin. The net result would be a
reduction in lactic acid production in the rumen of cattle, particularly during the
shift from roughage to high grain diets. In vitro fermentations of various sugars
and ground grains with rumen fluid from either hay- or grain-fed cattle indicate
monensin effectively reduced lactate production (Dennis et al., 1981c). Nagaraja et
al. (1981, 1982) reported prevention of glucose- or corn-induced lactic acidosis in
cattle by monensin. These observations indicate monensin may improve feed
efficiency by preventing clinical and subclinical cases of lactic acidosis in cattle
stressed with carboydrate.
Decreased proteolysis and deamination. Monensin may have a protein sparing
effect, possibly sparing amino acids normally used for gluconeogenesis (Leng et al.,
1967; Reilly and Ford, 1971). Numerous studies have shown monensin significantly
reduces ruminal degradation of dietary protein (Schelling et al., 1977; Van Nevel
and Demeyer, 1977; Poos et al., 1979; Chalupa, 1980). Schelling et al. (1977) have
aslo demonstrated that monensin decreased the rate of free amino acid degradation
in rumen fluid. Monensin has been shown to decrease bacterial N reaching the
abomasum of adapted steers, and increase the dietary protein reaching the
abomasum (Poos et al., 1979). This supports a protein-sparing effect of monensin by
increasing ruminal escape of dietary protein.
Depressed methane production. Another mode of action is depressed
methane production. In vitro studies indicate a decrease in microbial methane
production with monensin (Bartley et al., 1979; Chalupa, 1980). This has also been
demonstrated in vivo CJoyner et al., 1979; Thornton and Owens, 1981; Benz and
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Johnson, 1982). Monensin has been reported to select against hydrogen-producing
and formate-producing rumen bacteria thereby decreasing the precursors required
for methanogenesis (Chen and Wolin, 1979; Dennis et al., 1981a). Monensin has
been shown to decrease the metabolism of formate to carbon dioxide and hydrogen,
resulting in a decrease in methane production (Van Nevel and Demeyer, 1977).
Russell and Martin (1984) advanced a hypothesis that depression of methane
production in the presence of monensin was dependent on hydrogenase activity on
NADH
2
coupled to amino acid fermentation by rumen microorganisms. The
depression in methane production appears to be small, therefore resulting in only a
slight improvement in the efficiency of production.
Alterations in digestibility
. Several reports indicate an influence of
monensin on digestibility, but results are variable. Simpson (1978) found that
monensin decreased cellulose digestibility in cattle unadapted to monensin. Animals
with a 21 -day adaptation time to monensin had no effect on cellulose digestibility
(Dinius et al., 1976). No alteration in acid detergent fiber digestibility of forage
occurred when cattle were adapted to monensin for two weeks (Benz and Johnson,
1982). Several studies indicate increases in dry matter digestibility due to
monensin (Dinius et al., 1976; Poos et al., 1979; Thornton and Owens, 1981). It
appears that monensin, in general, results in a slight improvement in digestibility.
There appears to be many factors such as rate of passage, rumen fill, feed intake,
and diet which can influence the digestibility of the feed or feed component in
question. Research at this time indicates monensin may decrease rumen turnover
rate and increase rumen fill (Lemenager et al., 1978), but more research in this
area is warranted.
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Bloat prevention. Bloat is a disorder in ruminants with an unclear etiology.
Cattle have an intrinsic susceptibility to bloat that is determined genetically
(Clarke and Reid, 197*). Bloat can be characterized as either feedlot bloat (grain
bloat) or legume bloat. Both types are characterized by excessive foaming of
ruminal digesta. Feedlot bloat occurs in cattle fed large quantities of grain and
small quantities of roughage (Bartley et al., 1975). In legume bloat, although
ruminal microorganisms contribute to foaming, the primary foaming agents are
derived from plants (Clarke and Reid, 197*).
Bartley et al. (1982) observed that monensin reduced legume bloat in cattle
by about 66*. Monensin also reduced grain bloat by 64%. Sakauchi and Hoshino
(1981), have reported the anticoccidial action of lonophores tends to decrease total
protozoa in rumen contents. Monensin may therefore have a bloat depressing effect
by depressing putative slime production by protozoa.
Prevention of acute bovine pulmonary edema and emphysema. Acute bovine
pulmonary edema and emphysema (ABPE) or fog fever is a naturally occuring
disease of adult cattle characterized by sudden onset of acute respiratory distress
soon after a change to lush forage (Breeze and Carlson, 1982). ABPE is caused by
the formation, absorption and lung metabolism of 3-methyl indole (3MI) (Carlson et
al., 1975). L-tryptophan, a naturally occuring amino acid, is converted to
indolepyruvic acid which is then converted to indoleacetic acid in the rumen.
Indolepyruvic acid is then decarboxylated to 3M1, possibly by Lactobacilli
^p_.
(Yokohoma et al., 1977; Hammond et al., 1978).
A logical approach to control of ABPE would be to inhibit 3MI formation by
altering rumen fermentation. Studies have demonstrated that monensin can
effectively reduce 3MI production and prevent the clinical signs and pulmonary
lesions of ABPE (Hammond et al., 1978; Hammond and Carlson, 1980). In vitro
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studies (Honeyfield et al., 1985) have demonstrated a lower conversion of
tryptophan to 3MI from monensin treated cows compared with untreated cows.
Conversion of tryptophan to indole was also lower. Monensin also reduced in vivo
3MI production. These results indicate monensin reduced clinical cases of ABPE.
LASALOCID
Lasalocid is a carboxylic acid polyether ionophore (Fig 2) produced by
Streptomyces lasaliensis (Berger et al., 1951). Although structurally similar to
monensin, it differs in ion selectivity. Lasalocid is capable of transporting divalent
cations, in addition to monovalent cations. The cation selectivity has been
determined to be Ba+ » Cs+ > Rb+, K+ > Na+, Ca2+, Mg2+ >Li+ (Westley, 1982).
Lasalocid is also highly effective against gram-positive bacteria, including
Mycobacterium, but exhibits no activity against gram negative bacteria (Westley,
1977). Lasalocid possesses broad spectrum anticoccidial activity (Edgar and
Flanagan, 197*) in chickens and is marketed under the trade name of AvatecR
(Hoffmann-LaRoche Inc., Nutley, Nj").
Lasalocid is also effective in improving feed efficiency of ruminants. It is
approved under the trade name BovatecR (Hoffmann-La Roche Inc., Nutley, NJ) to
improve feed efficiency and rate of gain. It is also approved for use as a
coccidiostat in sheep. Number of trials have been conducted to compare the
efficacy of lasalocid with that of monensin in improving feed efficiency in cattle.
Recently a 17-trial study comparing lasalocid to monensin, when both feed
additives were fed at 30 g/ton was compiled by Stuart (1984). Lasalocid improved
feed conversion by 7.2% over the control treatment and 3.4% above the monensin
treatment. Feed intake was similar for lasalocid- and monensin-containing feeds
which were approximately 2% below the control feed mtake. Lasalocid increased
average daily gain by 5.3% above control and 4.2% above monensin (table 4).
COOH
Figure 2. Structure of Lasalocid
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TABLE *. COMPARATIVE EFFECTS OF LASALOCID AND MONENSIN ON
PERFORMANCE IN FEEDLOT CATTLE3
Average daily Average daily Feed conversion
Treatment gain (kg) feed intake (kg) (feed/gain)
Control 1.29
Lasalocid 1.36
Percent improvement
over control +5.3
Percent improvement
over monensin +4.2
Monensin 1.30
Percent improvement
over control +1.1 + 3_9
a
Stuart, 198*.
b,c,d,
,
Means in the same column with different superscripts are significantly
different (P<.05).
I0.06
b
7.94
b
9.S7
C
7.37
C
+7.2
+3.4
9.82
c
7.63
d
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The enhancement of feed efficiency is attributed to induced rumen
fermentation changes similar to those produced by monensin. The rumen
fermentation alterations which have been documented are:
1. Shift in the proportions of volatile fatty acids without affecting the
total production. Increased propionate and decreased acetate and
butyrate (Davis, 1978; Bartley et al., 1979; Fuller and Johnson 1981;
Thonney et al., 1981; Nocereni et al., 1985).
2. Decreased methane production (Bartley et al., 1979; Fuller and Johnson,
1981; Russell and Martin, 1984).
3. Decreased lactic acid production from carbohydrates (Dennis et al.,
1981c) and prevention of experimentally induced lactic acidosis (Nagaraja
et al., 1981, 1982).
4. Protein sparing effect by inhibiting proteolysis and deamination (Bartley
et al., 1979; Fuller and Johnson, 1981).
5. Selective inhibition of rumen bacteria (Dennis et al., 1981a).
6. Inhibition of rumen protozoa (Dennis et al., 1981b).
7. Prevention of frothy bloat in high-grain feed cattle (Bartley et al., 1982).
8. Reduction of 3-methylindole formation from tryptophan and control of
acute bovine pulmonary edema and emphysema (Nocereni et al., 1985).
Despite many similarities, the differences between the two antibiotics
appear to be in the degree of rumen fermentation changes induced. Bartley et al.
(1979) have reported that the extent of reduction in acetate-propionate ratio was
greater with lasalocid than monensin in a batch culture fermentation. Similar
difference was observed in VFA production in a continuous fermentation system
(Fuller and Johnson, 1981). Methane inhibition was greater with lasalocid than
monensin (Bartley et al., 1979). However, Fuller and Johnson (1981) and Russell and
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Martin (198*) found no difference in the extent of methane inhibition between the
two antibiotics. Fuller and 3ohnson (1981) reported that lasalocid addition to both
high-grain and roughage substrates in a continuous fermentor resulted in 17 to 18%
relative reduction in the fraction of nitrogen digested while monensin depresed N
digestibility by an average of 16% with high-gram substrate and by 24% with
roughage substrate.
Lasalocid has been reported to be much more effective than monensin in
inhibiting lactic acid production in vitro (Dennis et al., 1981c) as well as in the
prevention of experimentally induced lactic acidosis (Nagaraja et al., 1981, 1982).
Dennis et al. (1981a) determined that most of the lactate producing rumen bacteria
were sensitive to both lasalocid and monensin. Lasalocid inhibited all strains of ^.
bovis tested, while one strain (12*) was resistant to monensin. None of the lactate-
utilizing bacteria was sensitive to lasalocid or monensin. Therefore, it appears the
ability of lasalocid to prevent lactic acidosis to a greater degree than monensin
must be related to factors other than bacterial sensitivity.
The effect of lasalocid on frothy bloat has been determined (Bartley et al.,
1982). Lasalocid reduced legume bloat by 26% and grain bloat by 92%. The
effectiveness of lasalocid has been attributed to its unique ability to inhibit the
growth of all important strains of S^ bovis, a causitive organism in feedlot bloat
(Bartley et al., 1975).
Lasalocid has also been shown to prevent acute bovine pulmonary
emphysema and edema (ABPE) (Nocerim et al., 1985). In vitro conversion of
tryptophan to 3-methylindole and indole by rumen fluid was sharply reduced.
Lasalocid effectively reduced ruminal conversion of tryptophan to 3-methylindcle
and prevented the development of tryptophan induced ABPE in cattle.
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SALINOMYCIN
Salinomycin is a monocarboxylic acid polyether ionophore (Fig 3) produced
by Streptomyces albus (Kinashi et al., 1973). The cation selectivity has been
determined to be K+ > Na+ > Cs + » Ca++ (Westley, 1982). The antibiotic possesses
broad spectrum anticoccidial activity in chickens (Chappel and Babcock, 1979) and
is marketed as a coccidiostat under the trade name Bio-cox
. (Feed Additive
Compendium, 1985). Like lasalocid and monensin, the antibiotic is highly effective
against gram-positive bacteria including Mycobacterium
, but exhibits no activity
against gram-negative bacteria (Miyazaki et al., 1974; Liu, 1982).
Influence on cattle performance
. Because of the similarity of salinomycin to
lasalocid and monensin, studies have been conducted to evaluate its potential as a
feed additive. McClure et al. (1980) conducted a 126-d finishing trial with 48
yearling steers and heifers fed a 20* roughage diet supplemented with 0, 16.5,
33.0 and 50.0 g salinomycin per metric ton. Average daily gains were 1.30, 1.57,
1.47 and 1.33 kg and feed intakes were 11.0, 11.0, 10.4 and 10.2 kg"d
_1
for the
cattle fed diets containing 0, 16.5, 33.0 and 50.0 g salinomycin, respectively. Feed
efficiency was improved by 21% for the cattle fed salinomycin at 16.5 and 33.0
g/ton and 10% for those fed 50.0 g/ton. Owens et al. (1982) fed salinomycin at 0,
5.5, 11, 22 and 33 ppm of an 89% whole shelled corn and 5% cottonseed hull diet
to 140 finishing steers for 110 d. Averaged across salinomycin levels, gain was
increased 9.4% and feed efficiency increased 7.8%. Feed intake was increased by a
mean of 1% by salinomycin. At the optimum drug level of 11 ppm, gain and feed
efficiency were increased by 12.9 and 9.5%. Turgeon et al. (1982) tested
salinomycin at 0, 5.5, 11, 16.5 and 22 ppm in cattle fed 79.3% high moisture corn,
10% corn silage and 10.7% supplemented diet. Average daily gain was 1.25, 1.22,
1.20, 1.19 and 1.23 and feed conversion was 7.10, 6.88, 7.04, 7.12 and 6.84 for
Me M
Figure 3. Structure of oalinomycin
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cattle fed 0, 5.5, 11, 16.5 and 22 ppm salinomycin, respectively. Ferrell et al.
(1983) fed salinomycin at 0.5, 10, 15 and 20 g per ton of a ground corn based diet
to 1*0 finishing steers and heifers. Averaged across salinomycin levels, gam was
increased by 2.6% and feed efficiecy was improved by 7.8*. Salinomycin at 15
g/ton produced the optimum level of performance with an increase in rate of gain
and feed efficiency of 8.9% and 10.9%, respectively. Zinn and Axe (1983a)
conducted a 187-d growing finishing trial involving 150 large frame Okie calves to
determine the efficacy of salinomycin fed 0.5, 10, 15 and 20 g/ton airy dry feed.
Rate of gain was not influenced significantly however, feed efficiency was by an
average of 5.9% at 10 and 20 g/ton salinomycin supplementation.
In a trial involving 105 Angus x Hereford steers (Merchen and Berger,
1985), salinomycin was tested at 0, 5.5, 11, 22 or 33 ppm. Cattle were fed a diet
containing 60% corn silage at the beginning of the feeding period with a gradual
reduction to 15% corn silage: 85% grain over the first 21 d of a 13*-d trial.
Salinomycin level had a quadratic effect (P<.05) on daily weight gain and resulted
in a quadratic (PC05) decrease in feed intake with an average improvement of
10.3% in feed efficiency (table 5).
The effect of salinomycin on performance of cattle grazed on pasture
(Barclay et al., 198*; Bagley et al., 198*) and fed corn silage (Turgeon et al.,
1983) have been studied. Barclay et al. (198*) evaluated salinomycin levels of 0,
50, 100 and 150 mg'hd 'd in a grazing trial involving 96 yearling steers.
Salinomycin was provided in a .9 kg of ground corn per head fed once daily. Daily
gain for the 0, 50, 100 and 150 mg treatments was .35, .38, .*6 and .*! kg,
respectively. Bagley et al. (198*) fed salinomycin at 0, 50, 100 and 150 mg-hd" 1 ^" 1
in
.9 kg ground corn to yearling crossbred steers grazed on bermudagrass pastures.
Daily gains, total gains and final weights were greater for steers fed salinomycin
compared to the control diet. The ionophore increased gains by ** to 53% over
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control with shifts in ruminal VFA levels (table 6). Turgeon et al. (1983) fed
salinomycin at 0, 5.5, 11, 22 and 33 ppm to cattle fed 88% corn silage, 12%
soybean meal based supplemented diet. As the dietary level of salinomycin
increased, steers gained faster, consumed less feed and became more efficient.
Average daily gain was 1.21, 1.21, 1.27, 1.31 and 1.28 kg/d and feed coversion was
8.88, 8.66, 7.87, 7.83, 7.55 for steers fed salinomycin at 0, 5.5, 11, 22, and 33 ppm,
respectively.
Comparative effects of salinomycin with lasalocid or monensin on animal
performance. Animal performance trials involving dose titration studies have
suggested that optimum dosage of salinomycin was 10-15 g/ton of feed (Owens et
al., 1982; Ferrell et al., 1983; Turgeon et al., 1983; Zinn and Axe, 1983b; Bagley
et al., 198*; Barclay et al., 1984; Merchen and Berger, 1985). It appears that
salinomcyin is about two or three times as potent as lasalocid or monensin.
Heinemann (198*) conducted a 112-d feedlot trial involving 108 yearling
steers to compare the effects of monensin (300 mg"d" 1- hd"'), lasalocid (300
mg'd 'hd~ ) and salinomycin (100 mg"d" 1- hd"') on animal performance and
incidence of liver abscesses. The steers were fed 85% grain (17% cracked barley,
83% dry rolled corn) and 15% alfalfa cubes. Steers fed monensin gained slower than
lasalocid or salinomycin-fed steers. Steers fed salinomycin gained more efficiently
(6.31 kg feed/kg gain) than the controls (6.86) and those fed lasalocid (6.9*) and
monensin (6.78). Incidence of liver abscesses tended to be lower for steers fed
monensin.
1C6
TABLE 6. EFFECT OF SALINOMYCIN ON ANIMAL PERFORMANCE AND RUMEN
VOLATILE FATTY ACID (VFA) CONCENTRATION IN GRAZING BEEF
STEERS '
Salinomycin (mg'hd '•d- 1
,
Item 50 100 150 SE
No. of steers 10 10 10 10
Average daily gain, kg .49 .71 .73 .75 .12
Final weight, kg 277 310 317 318 8.6
Propionate, % 16.1 17.1 18.5 19.8 M
Total VFA, mM 101.2 95.7 9*.0 91.0 6.8
Acetate:propionate 4.37 4.23 3.86 3.56 .12
a
BagIey et al., 198*.
Grazed on bermuda grass pasture.
10?
Martin et al. (198*) conducted a study with yearling steers fed whole
shelled corn supplemented with salinomycin (10 g/ton of feed), lasalocid (30 g/ton
of feed) or monensin (25 g/ton of feed) plus tylosin (90 mg/head daily). Body
weight gains and feed efficiency were greatest for steers fed salinomycin.
Performance of steers on monensin-tylosin combinations was similar to that of
lasalcoid-fed steers (table 7).
Merchen and Berger (1985) conducted a trial involving 126 Charolais cross
steers to compare salinomcyin with that of monensin. The steers were on a diet of
90% concentrate (ground corn) and 10% oat silage. Salinomycin was fed at 5.5, 11,
16.5 adn 22 ppm and monensin at 22 ppm for 111 days. Addition of either
lonophore to the diet had no effect on feed intake. Steers fed 5.5 ppm of
salinomycin and 22 ppm monensin had more rapid rates of gain than did steers fed
the control diet. Steers fed higher levels of salinomycin had rates of gain
intermediate to these groups. Addition of either ionophore to the diet had no
effect on feed intake. No significant improvements in feed efficiency were noted
among treatments.
Effect on rumen fermentation and nutrient digestibility
. Fontenot et al.
(1980) conducted in vitro experiment to study the effect of 0, 3, 30 or 300 ppm
salinomycin with incubation times of 6, 12, 18 and 24 h on VFA level and dry
matter digestion. Molar proportion of propionic acid increased and of acetic acid
decreased with each increase in level of salinomycin at all incubation times. The
effect was smallest at 6 hours. Dry matter digestibility increased at 3 ppm level
and decreased at the higher levels. In a subsequent in vitro experiment in which
levels of salinomycin varied from to 55 ppm, molar proportions of propionic acid
increased and of acetic acid decreased with salinomycin level. In a 61 -d
experiment conducted with 30 yearling cattle individually fed an 80% concentrate
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TABLE 7. STEER PERFORMANCE WITH VARIOUS IONOPHORES AND
ANTIBIOTICS
Monensin (25 g/ton)
Item Control Salinomycin Lasalocid Tylosin
(10 g/ton) (30 g/ton) (90 mg"d hd )
No. of steers 32 32 32 31
Initial weight, kg 3*2.7 3*5.0 3*5.5 3*9.1
Final weight, kg *82.3C 512.7
5
*90.5
C
*98.2bc
Daily gain, kg I.12
c
1.38 1.17 1.32
Daily feed intake, kg 8.67c 9.**b 8.57 C 8.86bc
Feed/gain 7.55 6.86 7.37 7.35
a
Adapted from Martin et al., 198*.
' Means in a row with different superscripts differ (P<.05).
Composition of the diet (*): whole shelled corn 88.1*, corn silage *.00, soybean
meal 3.71, cottonseed meal 2.00, limestone 1. 00, urea .*5, molasses .38, salt .30
and premix .02 (11.8* crude protein).
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diet supplemented with 0, 5.5, 16.5, 33.0 and 50 g salinomycin per metric ton,
average molar proportion of propionic acid was 32%, 36, 3*, 43 and 41%,
respectively. Corresponding decreases in molar proportion of acetic, butyric, and
isovaleric acids were recorded (Fontenot et al., 1980).
Webb et al. (1980) conducted metabolism steers in 18 yearling steers fed
80% concentrate diet supplemented with salinomycin at 0, .4 and 0.8 mg'kg" 1 body
weight. Crude protein digestibility increased and crude fiber digestibility decreased
linearly as salinomycin intake increased. Salinomycin had no affect on nitrogen
retention or rumen pH, but decreased rumen ammonia-N levels. Molar proportions
of rumen propionate increased and acetate decreased with salinomycin intake.
There was a linear decline in butyrate and isovalerate and linear increase in
valerate as salinomycin intake increased. A linear decline in methane production
was also observed with increased salinomycin intake. Similar shifts in VFA
proportions have been reported by others (McClure et al., 1980; Bagley et al.,
1984).
Zinn and Axe (1983b) used four steer calves with cannulas in the rumen and
proximal duodenum in a 4 x 4 latin square design to test four levels of salinomycin
(0, 5, 10 and 15 g/ton air dry feed). Steers were fed a 90% concentrate diet.
Total tract digestion of organic matter, fiber, and protein was not significantly
altered by salinomycin supplementation. However, ruminal digestion of organic
matter was reduced 6.2%. Neither feed protein degradation in the rumen nor
microbial efficiency (g microbial N/kg organic matter fermented) was significantly
altered. Differences in rummal molar concentrations of acetate, propionate and
butyrate were non-significant. However, molar ratios of acetate and propionate
tended to be reduced at the 10 and 15 g/ton levels of salinomycin supplementation.
In a sheep digestion trial (Merchen and Berger, 1985), addition of salinomycin at
5.5, 11 or 22 ppm to 60% concentrate diets had no effect on apparent digestibility
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of dry matter, organic matter, neutral detergent fiber, acid detergent fiber or
starch in comparison with control diets. Apparent nitrogen digestibility was
increased in sheep fed salinomycin. Salinomycin did not affect total volatile fatty
acid concentrations in the rumen but resulted in a linear increase in molar
proportion of propionate and a linear decrease in molar proportions of acetate,
butyrate and in acetate: propionate ratios (table 8). The shifts in VFA proportions
were fully expressed within 4 d after salinomycin feeding (Merchen and Berger,
1985).
Salinomycin has been tested (Bartley et al., 1982) to determine its
effectiveness in preventing bloat. Salinomycin did not control bloat, thus
demonstrating that not all ionophores are equally effective in controlling feedlot
bloat.
NARASIN
Narasin is a polyether monocarboxylic ionophore produced by Streptomyces
aureofaciens (Dorman et al., 1976; Boeck et al., 1977; Berg and Hamill, 1978). The
cation selectivity for narasin has been determined to be Na+ > K+, Rb+ > Cs+ >
Li+ (Wong et al., 1977). Narasin is structurally similar to salinomycin except for
the additional methyl group on the 6-member cyclic either at the carboxylic
terminal (Fig 4, Occolowitz et al., 1976; Seto et al., 1977). Narasin was active in
vitro against gram-positive bacteria, anaerobic bacteria, fungi and some viruses
(Berg and Hamill, 1978). Narasin also possesses broad spectrum activity against
coccidial infections in chickens (Weppelman et al., 1977) and has been shown to
improve feed efficiency in ruminants (Schaeffer et al., 1975).
Dinusson et al. (1979) evaluated narasin as a feed additive in finishing diets
in a trial involving 54 Hereford steers. The diet was dry-rolled corn to appetite,
limited corn silage, chopped alfalfa hay and a commercial 32% protein liquid
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TABLE 8. EFFECT OF SALINOMYCIN ON RUMEN VOLATILE FATTY ACID
(VFA) CONCENTRATION IN SHEEP3 '
Salinorrlycin (ppm )
Item 5.5 11 22 SE
Rumen pH 5.87 5.95 5.90 5.93 .05
Total VFA, mM 104.4 98.4 91.9 104.6 4.20
Acetate, %C 57.8 55.4 50.4 49.7 2.20
Propionate, % 24.1 28.4 35.3 38.0 .94
Butyrate, %C 14.3 11.8 10.8 9.0 1.05
Acetaterpropionate ratio 2.48 2.04 1.42 1.32 .15
Merchen and Berger, 1985.
Values are means of samples taken 4 h postfeeding on d 4, 7, 10, 13 and 16 of
each period.
C
Linear effect (P<.05).
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Figure 4. Structure of Narasin
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supplement. The antibiotic was added to the supplement to approximate levels of 0,
* and 12 ppm in the diet. As compared to the control, steers fed 4 ppm narasin
gained 9.5% faster required 7.1% less feed dry matter for gain, whereas the steers
on 12 ppm narasin gained 12.1% faster and required 11.8% less feed dry matter.
Potter et al. (1979) used 120 cattle to study the effect of narasin upon
performance of feedlot cattle fed in group pens or in individual crates for 126
days. Narasin was fed at 0, 2.75, 5.5, 16.5 and 33 ppm. Narasin at all levels had
no influence on average daily gain but reduced feed intake and improved feed
efficiency in both group fed and individual fed cattle. In a second study, Hereford
steers averaging approximately 330 kg were allotted by weight to 10 pens and used
to compare the affects of feeding 0, 2, 8, 16 ppm of narasin on performance of
feedlot cattle over a 133-d period. Narasin reduced feed intake, improved feed
efficiency and increased ruminal molar proportion of propionate (table 9). The data
suggested that the optimal dose of narasin was between 8 and 16 ppm.
LYSOCELLIN
Lysocellin, a divalent ionophore (Fig. 5) produced by Streptomyces
tongwoodensis (Otake et al., 1975), has recently been evaluated as a possible feed
additive to improve the growth and feed efficiency of ruminants. Lysocellin has
been shown to significantly increase average daily gain and increase feed
efficiency in lambs (Wolfrom et al., 1983). Wolfrom et al. (1983) conducted in
vitro studies to determine the ability of lysocellin to alter the molar proportions of
volatile fatty acids. Lysocellin lowered the molar percentage of acetate and
increased the molar percentage of propionate, resulting in a lower
acetate:propionate ratio than either the control or the monensin treatments.
Calhoun et al. (1983) observed similar responses. They also noted a decrease in the
molar percentage of butyrate.
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TABLE 9. EFFECT OF NARASIN ON THE PERFORMANCE OF FEEDLOT
CATTLE
Item 2.0 8.0 16.0
Daily gain, kg 1.27 1.22 1.25 1.17
Dry matter intake, kg/d 11.5 10.3 9.6 9.6
Feed/gain, kg 9.1 8.t 7.8 8.2
Ruminal propionate, % 21.8 23.7 25.4 28.7
a
Potter et ai., 1979.
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Figure 5. Structure of Lysocellin
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LAIDLOMYCIN
Laidlomycin is a monovalent, polyether ionophore antibiotic produced by
Streptococcus eurocidicus. The antibiotic is structurally similar to monensin
(Kitame et al., 1974; Kitame and Ishida, 1976). The purified form of laidlomycin
was inhibitory to various Mycoplasma species, especially against Acholepiasma
laidlawu at the concentration of .16 ug/ml, but had no activity against bacteria,
fungi or yeast (Kitame et al., 1974). However, the antibiotic was effective in
controlling coccidiosis in chickens (Kitame et al., 1974). Acylation of laidlomycin
with straight-chain acyl groups from two to 12 carbon atoms tended to improve the
potency of the antibiotic (Spires and Algeo, 1983). Laidlomycin butyrate was more
potent than monensin in inhibiting lactic acid production and enhancing propionate
production in an in vitro fermentation system. In a continuous culture experiment
propionic acid production was increased from 22.9 mmol/d in control to 30.5 and
33.7 mmol/d in monensin and laidlomycin treated fermentations, respectively (Spires
and Algeo, 1983). In a 56-d trial involving 36 steers average daily gain was &%
better and feed efficiency was improved 20% in steers fed laidlomycin butyrate (33
mg/kg diet) and in monensin-fed steers (33 mg/kg diet) feed efficiency improved by
15% of the control steers (Spires and Algeo, 1983).
ACTAPLANIN
Actaplanin is a glycopeptide antibiotic, similar to avoparcin, produced by a
strain of Actinoplanes missounensis. The antibiotic has been shown to increase
propionate production in vitro and in combination with ionophore antibiotics,
acta-planin improves efficiency of feed utilization in ruminants (U.S. Patent No.
4,405,609). The interaction of actaplanin and ionophore antibiotics appears to be
synergestic (table 10). Gill and Owens (1984) tested the effects of narasin and
actaplanin in a trial involving 250 steers fed a high concentrate whole shelled corn
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TABLE 10. EFFECTS OF ACTAPLANIN AND NARASIN ON FEEDLOT
PERFORMANCE3
Control
Narasin + Actaplanin (g/ton)
Item 5 + 8 7.5 + 12 10 + 16
No. of cattle 21 22 31 2H
Average daily gain, kg 1.04c 1.10 bc l.l« b 1.06
bc
Daily feed intake, kg 6.6 6.7 6.8 6.4
Feed/gain 6.42b 6.08bc 5.98c 6.01 C
Gill, D.R. and F.N. Owens, 1984.
b c
' Means in a row with different superscripts differ (P<.05).
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grain baled diet for 168 days. Addition of narasin together with actaplanin
increased rate of gain slightly and improved feed efficiency (table 10). The lowest
levels of both narasin and actaplanin gave benefits equal to that of higher levels.
Actaplanin has also been tested as a feed additive to increase level and efficiency
of milk production by dairy cows. McGuffy et al. (1983b) fed actaplanin to 64
Holstein heifers to determine lactation performance in an experiment beginning
four weeks postpartum. Actaplanin was fed at 0, 400, 800 or 1200 mg daily in a
diet commposed of 52.5* corn silage 17.5* alfalfa hay and 30% concentrate. After
eight weeks, actaplanin was withdrawn from the diet of half of the heifers in each
treatment, while remaining heifers received actaplanin for a complete lactation.
Average daily milk production was higher at all levels of actaplanin in both group
of heifers. In another study (McGuffy et al., 1983a) involving 399 Holstein cows at
seven lacations actaplanin was tested at 0, 400, 800 or 1200 mg per day for 280
days. Milk production and efficiency of production were increased by actaplanin,
while percent milk components were decreased by feeding 800 and 1200 mg (table
11).
AVOPARCIN
Avoparcin is a glycopeptide antibiotic (Fig 6) produced by a strain of
Streptomyces candidus (Kuntsman et al., 1969). The antibiotic is a water soluble
compound and its production, isolation, physiochemical and structural properties
have been reported (Kuntsman et al., 1969; Hlavka et al., 1974; McGahren et al.,
1980). The antibiotic possesses a strong affinity for the cell walls of gram-positive
bacteria and disrupts peptidoglycan synthesis by inhibiting the incorporation of
N-acetyl glucosamine and is ineffective against gram-negative bacteria (Redin and
Dornbush, 1968). Avoparcin is not active against all gram-positive bacteria. Walton
(1978) noted that avoparcin was not inhibitory to some gram-positive enteric
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TABLE 11. EFFECT OF ACTAPLANIN ON MILK PRODUCTION AND EFFICIENCY 3
Actapl anin, mg/d
Item WQ 800 1200
Milk, kg/d 23.
3
b
2*.3
C
24.6
C
24.4
C
Fat, % 3.78b 3.69bc 3.58cd 3.51 d
Protein, % 3.*6b 3.*« b 3.38c 3.36C
Total solids, % 12.62 b 12.48bc 12.41 Cd 12.30d
Dry matter intake
,
kg/d 18.3 18.4 18.3 18.0
Milk/DMI I.30C 1.35bc 1.38 b 1.39b
a
McGuffy et al., 1983b.
°>c >d»iMeans in the same row with different superscripts differ (P<.05).
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streptococci and pharyngeal staphylococci in chickens and Dutta and Devriese
(1981) have described a number of lactobacilli against which avoparcin had no
activity. Stewart et al. (1983) studied the effect of avoparcin on pure and mixed
cultures of rumen bacteria. Of the gram-negative bacteria tested, all except B.
succinogenes were able to grow in the presence of 200 ug avoparcin ml" . Among
the gram-positive bacteria, L. acidophilus and L. casei were the most highly
resistant. Those bacteria which often stain gram-negative but possess cell walls
with gram-positive structure such as B. fibrisolvens, L. multiparus and the
ruminococci were all among the most sensitive organisms. However, avoparcin had
no effect on the in vitro digestion of dried grass and straw.
Avoparcin has been shown to be a growth promotant in broiler chickens
(Leeson et al., 1980), turkeys (Leeson and Summers, 1981) and in pigs (Schneider et
al., 1979). Avoparcin has been used extensively in the feed of broiler chickens and
pigs under commercial conditions in the United Kingdom (trade name 'Avotan') and
Europe since 1976 to improve rate of live-weight gain and efficiency of feed
conversion, and since 1981 in turkey feeds for the same purposes.
Since the last 5 to 6 years avoparcin has been tested as a possible feed
additive for ruminants. Ingle et al. (1978) demonstrated from in vitro studies that
avoparcin decreased the acetate:propionate ratio without altering the production
of total VFA. Addition of avoparcin at 100-1000 ppm to an in vitro rumen fluid
incubation system depressed acetateipropionate ratio by 20-200%. In another study
rumen samples were collected from three groups of six steers each fed a 6056
roughage diet containing 0, 33 and 99 ppm avoparcin. The acetateipropionate ratio
and percent change from control for the samples taken from 0, 33 and 99 ppm
avoparcin fed steers were 3.74, 0%; 2.80, 23%; and 2.08, 44% at 28 days and 3.39,
0%; 2.54, 21%; and 2.08, 39% at 56 days, respectively. Over the 56-day period
avoparcin supplementation decreased feed intake and improved feed conversion
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(Ingle et al., 1978). Further studies conducted in the United States and Europe
have confirmed the effect of avoparcin on rumen fermentation (Johnson et al.,
1979; Dyer et al., 1980; Chalupa et al., 1981; Macgregor and Armstrong, 1982; and
Froetschel et al., 1983) and on the performance of beef cattle (Embry et al., 1979;
Johnson et al., 1979; Sherrod et al., 1979; Dyer et al., 1980; Owens and Gill, 1981;
Mudd and Smith, 1982; Cuthbert et al., 198*).
Froetschel et al. (1983) studied the effect of avoparcin on ruminal
propionate production and amino acid degradation by using four rumen-fistulated
wethers. Wethers were fed each of four diets during 28-day peirods in a * x 4
Latin square design. Diets were high fiber, high-fiber plus 50 ppm avoparcin, low
fiber and low-fiber plus 50 ppm avoparcin. Propionate production was determined
by isotope dilution technique (single injection). Avoparcin decreased total VFA
concentration, increased ruminal pH and molar proportion of propionate on both
high fiber and low-fiber diets (table 12). Daily propionate production and pool
turnover rate increased in sheep fed avoparcin. Avoparcin decreased ruminal
ammonia (50 vs 45 mg/100 ml) and increased a -amino nitrogen (8.6 vs 14.3 mM) in
low fiber fed sheep. They concluded that avoparcin modifies rumen fermentation by
increasing propionate production and inhibiting protein or amino acid degradation.
The effect of avoparcin on feedlot performance is equal to or superior to
that of monensin (Johnson et al., 1979; Dyer et al., 1980; Owens and Gill, 1981).
Johnson et al. (1979) used 150 yearling steers to evaluate the effect of 0, 16.5, 33
and 60 ppm avoparcin and 33 ppm monensin in the feed on growth rate, feed
efficiency, and the concentration of volatile fatty acids in the rumen. Avoparcin
at all levels improved feed efficiency and produced daily gains that were greater
than untreated control or monensin treated steers (table 13). Ruminal propionate
increased due to avoparcin ingestion. Dyer et al. (1980) used 150 crossbred yearling
heifers fed a 77% barley diet for 140 days to evaluate the effect of 0, 33, 49.5
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TABLE 12. EFFECT OF AVOPARCIN ON RUMEN VOLATILE FATTY ACID (VFA)
CONCENTRATION IN SHEEP3
High- fiber diet Low- fiber diet
Item Contro 1 Avoparcin
(50 ppm)
Control Avoparcin
(50 ppm)
Total VFA, mM 124.0 110.9 112.0 88.9
Acetate, * 62.8° 61.
8
C
56.9
d
57.5
d
Propionate, % 19.0C 23.2d 19.5C 23.9 d
Isobutyrate, % 1.4 1.5 1.6 1.9
Butyrate, % 13.4° 10.7d 16.1 c 12.6 d
Isovalerate, % 2.1 1.6 3.5 2.5
Valerate, % 1.3 1.3 2.3 1.6
Acetate:Propionate ratio 3.4C 2.7d 3.1 c 2.5 d
Values are means of 72 observations collected from 4 sheep. Froetschel et al.,
b_
Composition of the diets (%): High-fiber diet - alfalfa pellets 71, corn 24
molasses 4.5, trace mineral salt 0.5, low-fiber diet - alfalfa pellets 25, corn 50,
soybean meal 20, molasses 4.5, trace mineral salt 0.5 (crude protein 19.0 and 22 1
respectively).
Means within a row with unlike superscripts differ significantly (PC05).
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TABLE 13. EFFECT OF AVOPARCIN AND MONENSIN ON STEER PERFORMANCE 3
A.voparcin Monensin
Item Control 16.5 ppm 33.0 ppm 66.0 ppm 33.0 ppm
No. of steers 29 30 30 30 30
Initial weight, kg 272.40 273.3 273.8 274.8 275.8
Final weight (112 d), kg 404.1 407.2 415.5 418.9 399.0
Daily gain, kg 1.1
8
bc
I.19
cd
1.27
cd
1.28
d
1.10
b
Daily feed intake, kg
e
10.55
b
10.37
bc
10.62
b
I0.54
b
9.87
c
Feed/gain 8.97 8.71 bc 8.38cd 8.19d 8.97 b
Adapted from Johnson et al., 1979.
b
>c >d
.,Means in a row with unlike superscripts differ (P<.05).
Composition of the diet (%): alfalfa pellets 50.0, steam rolled barley 44.4, salt
.50, trace minerals .05, vitamin A premix .05, fine ground corn 4.87 and antibiotic
premix 0.02.
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and 66 ppm avoparcin and 33 ppm monensin on growth rate feed efficiency and
ruminal VFA concentation. Average daily feed intake for cattle fed 49.5 ppm
avoparcin or 33 ppm monensin was lower than that for cattle fed the control diet
but not different from average intake for heifers fed cattle 33 or 66 ppm
avoparcin. Since there were no treatment differences in average daily gain, the
lower feed intake by heifers given 49.5 ppm avoparcin indicated that the level of
avoparcin was near to optimal dose for cattle. Feed efficiency at each level of
avoparcin was higher than that of the control but no difference in feed efficiency
between control and monensin-fed heifers was observed. Although there was no
difference in rumen VFA concentration between treatments, there was a trend for
lower acetate and higher propionate with increased level of avoparcin. Owens and
Gill (1981) have reported that avoparcin fed at 60 g per ton of feed decreased
feed intake by 11.5* and rate of gain by 6.8* for a feed efficiency improvement
of 5.1*. Similar values for monensin at 30 g per ton of feed were a 4.6* decrease
in feed intake, a 1.5* increase in rate of gain and a 6.0* improvement in feed
efficiency. Fecal pH tended to be lower and fecal starch higher with avoparcin
feeding (Owens and Gill, 1981).
THIOPEPTIN
Thiopeptin, a sulfer containing peptide antibiotic (Fig 7) produced by
Streptomyces tateyamensis (Miyairi et al., 1970), exhibits strong antimicrobial
activity against gram-positive microorganisms (Miyairi et al., 1972). The
antibacterial activity is because of inhibition of protein synthesis by blocking
elongation of peptide chain on the 505 ribosomal unit (Liou et al., 1976).
Thiopeptin supplemented feeds have been shown to improve weight gain, feed
efficiency in chickens and swine and the egg performance of layers (Mine et al.,
1972). Muir and Barreto (1979) evaluated the ability of various antibiotics including
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thiopeptin to inhibit S. bovis. Of the antibiotics evaluated thiopeptin was among
the most effective inhibitor of S. bovis Thiopeptin's effect on S. bovis prompted
the researchers to investigate its potential at controlling lactic acidosis. Muir et
al. (1980b) determined the efficacy of thiopeptin in preventing lactic acidosis in
lambs challenged by intraruminal administration of ground wheat (40 g/kg body
weight). Thiopeptin given as a single dose prevented lactic acidosis by reducing
rumen lactate 80 to 90%. In addition thiopeptin permitted normal rumen
fermentation to continue as indicated by a significant increase in volatile fatty
acids. The minimum effective dose of thiopeptin to control acute lactic acidosis
was .18 mg/kg body weight. Similar protection from induced lactic acidosis with
thiopeptin supplementation was also observed by Kezar and Church (1979). Because
acidosis is frequently encountered when high concentrate diets are fed to feedlot
cattle, supplementation of thiopeptin may improve performance and feed efficiency
by preventing clinical and subclinical acidosis. Gill et al. (1979) fed thiopeptin (11
ppm) with a high-concentrate rolled corn diet in a factorial experiment with two
roughage levels (15 and 5* cottonseed hulls) and two diet adaptation schemes (diet
changes from 40 to 20% roughage and to the final roughage level at 6- or 12-d
intervals) to 111 growing steers. Thiopeptin supplementation increased rate of gain
by 5.3% and feed efficiency by 7.8% over the 129-day trial (table 14). Incidence
and severity of liver abscesses tended to be higher in thiopeptin supplemented
steers. Muir et al. (1980a) evaluated thiopeptin at 0, 2.75, 5.5, 8.25, 11, and 22
ppm in the feed in 8-week growth trials involving 252 lambs. An abrupt shift to
micronized milo at the start of the trials was used to provide a lactic acidosis
challenge. Five of 78 control lambs died within 48 h after the challenge. In lambs
fed diets containing thiopeptin at 11 ppm or more, there was no evidence of lactic
acidosis. Lambs given thiopeptin at 11 ppm or more ate 11% more and gained 20%
more than control during the 8-week trial. Incidence of death was lower among
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TABLE 14. EFFECT OF THIOPEPTIN ON CATTLE PERFORMANCE3
Thiopeptin level, g/ton
Item 11 SE
No. of steers 55
Initial weight, kg 301
Daily gain (129 d), kg 1.38
Daily feed intake, kg 8.93
Feed/gain 6.48 b
Liver abscesses 29.5
300
1.45 .025
8.73 .118
6.00
c
.073
35.7 8.3
a
Adapted from Gill et al., 1979.
' Means in a row with different superscripts differ significantly.
Composition of the diet (%): Rolled corn 73.8, cottonseed hulls 15.0, alfalfa meal
4.0, cane molasses 4.0, cottonseed meal 4.5, limestone .75, urea, .5, dicalcium
phosphate .15, salt .3, vitamin A .015 and thiopeptin premix (11.8% crude protein).
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lambs given thiopeptin at 2.75 to 8.25 ppm but these animals showed no
improvement in performance. In another study, forty angus steers were tested for
the effect of thiopeptin on performance following a lactic acidosis challenge (Muir
et al., 1981). Steers that were abruptly shifted to micronized milo developed
ruminal lactic acidosis. Thiopeptin at 11 ppm in the feed prevented lactic acidosis
and improved weight gain, feed intake and efficiency of feed utilization at 2
weeks. At 4 weeks steers fed thiopeptin were still performing better than controls,
but the differences were not statistically significant. The efficacy of thiopeptin in
preventing lactic acidosis was compared with that of lasalocid or monensin by
Nagaraja et al. (1982). Lasalocid, monensin or thiopeptin was administered
intraruminally each at .33, .65 or 1.3 mg/kg body weight. Four rumen-fistulated
cattle were used for each dosage level and the design was a * x 4 Latin square,
with each animal receiving lasalocid, monensin, thiopeptin or no antibiotic.
Acidosis was reduced by intraruminal administration of glucose at 12.5 g/kg body
weight. At all three dosage levels cattle given lasalocid had higher rumen pH and
lower lactate concentration than did control cattle or cattle given monensin or
thiopeptin. Cattle given monensin had a slightly higher rumen pH and a lower
lactate concentration than the controls only at the .65 and 1.3 mg/kg body weight
dosages, whereas thiopeptin was effective only at 1.3 mg dosage. Colony counts of
Streptococcus bovis and Lactobacillus were significantly reduced in rumen fluid of
cattle given 1.3 mg antibiotic/kg body weight. Counts of lactate-utilizing bacteria
increased in both control cattle and cattle given antibiotics.
TYLOSIN
Tylosin is a macrolide antibiotic (Fig 8) produced from the fermentation of
a strain of Streptomyces fradiae (Berkman et al., 1961). Macrolides contain a large
lactone ring (12-16 atoms) having few double bonds and no nitrogen atoms; in
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addition, the ring is substituted with one or more sugar residues, some of which
may be amino sugars. The antibiotic has in vitro activity against many
gram-positive bacteria, some gram-negative bacteria (not coliforms), spirochetes
and most species of mycoplasma (McGuire et a]., 1961). The mechanism of
antibacterial action of tylosin, like other macrolide antibiotics is believed to be
due to inhibition of bacterial protein synthesis possibly by binding with ribosomes
(Vazquez, 1967). The usefulness of tylosin as a therapeutic agent against many
diseases of animals has been established by experimental studies and clinical
evaluations (Sampson et al., 1974a,b,c, 1975; Matsuoka et a!., 1980, 1983).
D
Tylosin is commercially available under the trade name Tylan (Elanco
Products Co., Indianapolis, IN) and is approved in chickens and swine to increase
rate of weight gain and improved feed efficiency. Tylosin is also recommended for
use in the control of chronic respiratory disease caused by Mycoplasma
gallisapticum and in the prevention of swine dysentary (vibrionic). In beef cattle
tylosin is fed at 8-10 g/ton of feed for the reduction of incidence of liver
abscesses caused by Fusobacterium necrophorum and Corynebacterium pyogenes.
Tylosin is also indicated for use in the treatment of bovine respiratory complex
associated with pasteurella multocida and corynebacterium pyogenes , foot rot and
diphtheria caused by Fusobacterium necrophorum and metritis caused by
Corynebacterium pyogenes in beef cattle. (Feed Additive Compendium, 1985).
Akkad and Hobson (1966) tested the antibacterial activity of tylosin towards
certain species of rumen bacteria. Gram-positive bacteria like S. bovis, L. bifidus
and L. fermenti were sensitive and gram-negative bacteria like M. elsdenii
,
Veillonella gazogenes, B. amylophilus and S. ruminatium were resistant. R. albus
and B. fibrisolvens that have gram-positive cell wall structure were also sensitive.
Wang et al. (1969) tested 15 species of rumen bacteria against tylosin in
concentrations ranging from 0.1 to 200 ug/ml in an anaerobic tube dilution system.
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R. flavefaciens, E. limosum and a Spirillum species were most sensitive to tylosin
(MIC 1 ug/ml) and B. ruminicola, B. succinogenes and R. albus were moderately
sensitive (MIC 10 ug/ml). B. fibrisolvens
, E. ruminantium
,
L. multiparus
, M.
elsdenii, S. bovis, Succinimonas amylolytica and Succinivibrio dextrmosolvens were
sensitive only at high concentration (MIC >_ 100 ug/ml), whereas B. amylophilus and
S. ruminantium were completely resistant to tylosin. Although the major
lactate-producing bacteria S. bovis and Lactobacillus species were resistant to
tylosin, Beede and Farlin (1977) reported that in an in vitro fermentation system
tylosin reduced lactate production.
The extensive use of tylosin in feedlot cattle is for the reduction of the
incidence of liver abscesses. It is routinely used in combination with monensin.
Liver abscesses in cattle are part of a disease complex where the abscessation is
secondary to primary foci of infection in the rumen epithelium (Jensen et al.,
195*). Ruminal lesions induced by increased acidosis that follows rapid change in
the diet from high roughage to highly fermentable carbohydrate or prolonged
feeding of high-grain diet (Brent, 1976) permit rumen bacteria to penetrate into
the hepatic portal venous system, which are then carried to the liver. Numerous
studies on the bacterial flora of bovine liver abscesses (Scanlan and Hathcock,
1983) have suggested, F. necrophorum (a normal inhabitant of the rumen) alone or
in combination with Corynebacterium pyogenes as the main etiologic agents. Liver
absecess in feedlot cattle is a serious economic problem in the cattle industry. The
incidence of abscessed livers in grain-fed cattle varies from as low as k to 5% to
as high as 90%. It is not uncommon to find 25 to 30% abscessed livers in feedlot
cattle at slaughter (Farlin, 1980). In addition to the loss of liver at slaughter,
reduced weight-gain and feed efficiency in cattle with abscessed livers compared
to cattle with healthy livers account for the economic loss (Goodrich et al., 1976).
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Brown et al. (1973) conducted four 4 feedlot experiments with 774 cattle on
high concentrate diets to evaluate two forms of tylosin (tylosin phosphate and
tylosin urea adduct) fed at 0, 50, 75 and 100 mg'hd" "d~ . Continuous
administration of tylosin of both forms at three levels reduced the incidence of
liver abscesses (24.1% control vs 4.2% treated), increased average daily gain (1.01
kg control vs 1.07 kg treated) and improved feed efficiency (7.65 control vs 7.41
treated). In another study involving 1829 cattle, Brown et al. (1975) compared the
effect of 75 mg tylosin with that of 70 mg chlorotetracycline on the incidence of
liver abscesses. Continuous administration of these antibiotics reduced the
incidence of liver abscesses and improved average daily gain and feed conversion
(table 15).
VIRGINIAMYCIN
Virginiamycin, a mixutre of two distinct antibiotic entities (Fig 9) that are
synergistic in their antimicrobial effect directed primarily against gram-positive
microorganisms, is produced by Streptomyces virginiae (Cocito, 1979). Cocito (1979)
characterized virginiamycin as non-toxic, poorly absorbed from the intestinal tract,
and highly biodegradable in animal waste. Virginiamycin improves feed utilization
and growth rate for non-ruminating animals. Growth studies in poultry (March et
al., 1978), veal calves (Parigi-Bini and Chiericato, 1979) and swine (Cromwell et
al., 1981; Pelura et al., 1980) indicate virginiamycin is a positive factor in the
production of non-ruminating livestock.
Virginiamycin is primarily active against gram positive bacteria (Cocito,
1979). Virginiamycin has been shown to control necrotic enteritis infection in
chickens, the causitive agent of which is the gram-positive Clostridium perfringens .
Virginiamycin has been reported to control swine dysentery and inhibit the growth
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TABLE 15. EFFECT OF TYLOSIN AND CHLORTETRACYCLINE ON THE
INCIDENCE OF LIVER ABSCESSES IN FEEDLOT CATTLE3
Tylosin Chlortetrocycline
Control 75 mg/d 70 mg/d
Incidence of
liver abscesses, % 56.1 1S.6 44.2
Improvement over
control, % 66.9 21.3
Average daily
gain, kg 1.10 1.17 1.14
Improvement over
control, % +5.8 +3.3
Feed/gain 8.21 8.14 7.87
Brown et al., 1975.
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of Treponema hyodysentenae
, the primary cause of swine dysentery (Williams and
Babcock, 1976; Williams and Shively, 1978).
In vitro studies (R.E. Hedde, Personal Communication) found that
virginiamycin shifts volatile fatty acid production proportions toward propionate
with a corresponding reduction in butyrate. They concluded that virginiamycin has
selective effects on rumen ecology resulting in fermentation changes similar to
lonophores in volatile fatty acid effect. Virginiamycin was specifically inhibitory to
D(-) and L(+) lactic acid producing bacteria (Streptococcus bovis and Lactobacillus
ruminis ) but not to lactate-utilizing bacteria (M. elsdemi) selective inhibition of
lactic acid production by virginiamycin was noted during in vitro glucose
fermentation in a nonbuffered inoculum derived from roughage-fed cattle.
Virginiamycin at 30 ppm in the diet protected against increased production of
rumen lactic acid during the change from roughage to concentrate diet in cattle.
Rumen L(+) lactate concentration increased in the control treatment but not in the
virginiamycin treatment following 35 days of continuous concentrate feeding. Also,
virginiamycin appeared to increase feed intake during concentrate feeding (R.D.
Hedde, Personal Communication).
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ABSTRACT
Sensitivity and resistance of rumen bacterial species to avoparcin, narasin,
salinomycin, thiopeptin, tylosin, virginiamycin and two new ionphore antibiotics,
RO22-6924/004 and RO21-6447/009, were determined. Generally, antimicrobial
compounds were inhibitory to gram-positive bacteria and those bacteria that have
gram-positive-like cell wall structure. Minimum inhibitory concentration (MIC)
ranged from 0.09 to 24.0 ug/ml. Gram-negative bacteria were resistant at the
highest concentration tested (48.0 ug/ml). Based on the fermentation products
produced, rumen bacteria that produce lactic acid, butyric acid, formic acid or
hydrogen were sensitive and bacteria that produce succinic acid or ferment lactic
acid were resistant to the antimicrobial compounds. Selenomonas ruminantium was
the only major lactic acid-producing bacteria sensitive to all the antimicrobial
compounds tested. Avoparcin and tylosin appeared to be less inhibitory (MIC > 6.0
ug/ml) than the other compounds to the two major lactic acid-producing bacteria,
Streptococcus bovis and Lactobacillus sp. Ionophore compounds seemed to be more
inhibitory (MIC 0.09 - 1.50 ug/ml) than the non-ionophore compounds (MIC 0.75 -
12.0 ug/ml) to the major butyric acid-producing bacteria. Treponema bryantii
, an
anaerobic rumen spirochete was less sensitive to virginiamycin than to the other
antimicrobial compounds. It appears that minimum inhibitory concentration is not a
good indicator of the potency of the antimicrobial compounds in altering rumen
fermentation characteristics.
Batch culture fermentations were used to determine the effect of
avoparcin, lasalocid, monensin, narasin, salinomycin, thiopeptin, tylosin,
virginiamycin and two new ionophore compounds (RO22-6924/004 and
R02 1-6447/009) on lactic acid and volatile fatty acid production. Preliminary
experiments were conducted with salinomycin to determine the effects of
incubation time and rumen fluid inoculum source on lactic acid and VFA
production. Maximum inhibition of lactic acid by salinomycin was at 6 h incubation,
but 12 h incubation showed a more graded response to antibiotic concentration.
Lactic acid inhibition by salinomycin was unaffected by rumen fluid inoculum
source. All antimicrobial compounds were effective in inhibiting lactic acid
production. Among the ionophores, narasin and salinomycin were more inhibitory
than others. Monensin and tylosin in combination was more effective than monensin
alone. Maximum alternations in VFA production by salinomycin were obtained in
fermentations incubated for 12 h with rumen fluid inoculum from low-grain fed
cattle. In general, total VFA concentration was unaffected by antimicrobial
compounds except that of RO22-692<t/00<f, tylosin and virginiarnycin which caused a
reduction at high concentrations. The acetate proportion was not affected by
avoparcin, RO22-692't/00<t, RO21-6W/009, lasalocid, monensin, narasin and
salinomycin. However, tylosin, monensin and tylosin in combination, thiopeptin and
virginiarnycin at high concentrations (> 6.0 ug/ml) increased the acetate
proportion. All compounds increased the molar proportion of propionate. Tylosin
and virginiarnycin at high concentrations (> 6.0 ug/ml) decreased the proportion of
propionate. Monensin and tylosin combination had no effect on propionate portion.
Narasin and salinomycin were the most effective among the compounds tested, in
enhancing propionate production. Ionophore antibiotics were more inhibitory to
butyrate production than the nonionophore compounds. Molar proportions of
isobutyrate, isovalerate and valerate were generally not affected by the addition
of antimicrobial compounds.
